<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD005947.pub4" GROUP_ID="NEONATAL" ID="520005111714431370" MERGED_FROM="" MODIFIED="2014-12-03 17:44:16 +0000" MODIFIED_BY="Yolanda Brosseau" NOTES="&lt;p&gt;Exported from Review Manager 4.2.8&lt;/p&gt;&lt;p&gt;Old title: Glutamine supplementation for infants with severe gastrointestinal disease&lt;/p&gt;&lt;p&gt;CL 2/06 (protocol)&lt;br&gt;CL 1/07 (review)&lt;/p&gt;" NOTES_MODIFIED="2014-12-03 12:43:25 -0500" NOTES_MODIFIED_BY="Yolanda Brosseau" REVIEW_NO="" REVMAN_SUB_VERSION="5.2.3 " REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="6.0">
<COVER_SHEET MODIFIED="2014-12-03 17:44:16 +0000" MODIFIED_BY="Yolanda Brosseau">
<TITLE>Glutamine supplementation for young infants with severe gastrointestinal disease</TITLE>
<CONTACT MODIFIED="2014-12-03 17:44:16 +0000" MODIFIED_BY="Yolanda Brosseau"><PERSON ID="11151" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>William</FIRST_NAME><LAST_NAME>McGuire</LAST_NAME><POSITION>Professor of Child Health</POSITION><EMAIL_1>William.McGuire@hyms.ac.uk</EMAIL_1><ADDRESS><ORGANISATION>Hull York Medical School &amp; Centre for Reviews and Dissemination, University of York</ORGANISATION><CITY>York</CITY><REGION>Y010 5DD</REGION><COUNTRY CODE="GB">UK</COUNTRY><PHONE_1>44 01904 321695</PHONE_1><FAX_1>44 01904 321696</FAX_1></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2014-12-03 17:44:16 +0000" MODIFIED_BY="Yolanda Brosseau"><PERSON ID="00537277744985685311111102161515" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Jennifer</FIRST_NAME><MIDDLE_INITIALS>VE</MIDDLE_INITIALS><LAST_NAME>Brown</LAST_NAME><POSITION>Research Fellow</POSITION><EMAIL_1>jennifer.brown@york.ac.uk</EMAIL_1><ADDRESS><ORGANISATION>Centre for Reviews and Dissemination, University of York</ORGANISATION><CITY>York</CITY><COUNTRY CODE="GB">UK</COUNTRY></ADDRESS></PERSON><PERSON ID="29008725616209149332111102161712" ROLE="AUTHOR"><PREFIX>Mrs</PREFIX><FIRST_NAME>Thirimon</FIRST_NAME><LAST_NAME>Moe-Byrne</LAST_NAME><POSITION>Research Fellow</POSITION><EMAIL_1>moe.byrne@york.ac.uk</EMAIL_1><ADDRESS><ORGANISATION>Centre for Reviews and Dissemination, University of York</ORGANISATION><CITY>York</CITY><COUNTRY CODE="GB">UK</COUNTRY></ADDRESS></PERSON><PERSON ID="11151" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>William</FIRST_NAME><LAST_NAME>McGuire</LAST_NAME><POSITION>Professor of Child Health</POSITION><EMAIL_1>William.McGuire@hyms.ac.uk</EMAIL_1><ADDRESS><ORGANISATION>Hull York Medical School &amp; Centre for Reviews and Dissemination, University of York</ORGANISATION><CITY>York</CITY><REGION>Y010 5DD</REGION><COUNTRY CODE="GB">UK</COUNTRY><PHONE_1>44 01904 321695</PHONE_1><FAX_1>44 01904 321696</FAX_1></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2014-10-09 11:43:13 -0400" MODIFIED_BY="[Empty name]">
<UP_TO_DATE>
<DATE DAY="9" MONTH="10" YEAR="2014"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="23" MONTH="9" YEAR="2014"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="10" MONTH="10" YEAR="2016"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="2" YEAR="2006"/>
<REVIEW_PUBLISHED ISSUE="1" YEAR="2007"/>
<LAST_CITATION_ISSUE ISSUE="12" YEAR="2014"/>
</DATES>
<WHATS_NEW MODIFIED="2014-10-09 06:51:50 -0400" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_OLD_CONCLUSIONS" MODIFIED="2014-10-09 06:51:50 -0400" MODIFIED_BY="[Empty name]">
<DATE DAY="9" MONTH="10" YEAR="2014"/>
<DESCRIPTION>
<P>Updated search in September 2014 identified one new study (<LINK REF="STD-Ong-2012" TYPE="STUDY">Ong 2012</LINK>) (publication of the SIGN trial previously identified as ongoing) for inclusion in this review.</P>
<P>The status of trial <LINK REF="STD-NCT00647036" TYPE="STUDY">NCT00647036</LINK> is not known.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2014-09-25 09:54:55 -0400" MODIFIED_BY="[Empty name]">
<DATE DAY="25" MONTH="9" YEAR="2014"/>
<DESCRIPTION>
<P>This updates the review "Glutamine supplementation for young infants with severe gastrointestinal disease" published in The Cochrane Database of Systematic Reviews (<LINK REF="REF-Brown-2012" TYPE="REFERENCE">Brown 2012</LINK>).</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2014-10-09 06:51:23 -0400" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_OLD_CONCLUSIONS" MODIFIED="2014-10-09 06:51:23 -0400" MODIFIED_BY="[Empty name]">
<DATE DAY="29" MONTH="3" YEAR="2012"/>
<DESCRIPTION>
<P>Updated search in November 2011 did not identify any new studies for inclusion in this review.</P>
<P>One new potentially relevant ongoing trial was identified (<LINK REF="STD-NCT00647036" TYPE="STUDY">NCT00647036</LINK>). The status of another possibly ongoing trial is not known (SIGN).<BR/>
</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2014-09-25 09:56:23 -0400" MODIFIED_BY="[Empty name]">
<DATE DAY="29" MONTH="3" YEAR="2012"/>
<DESCRIPTION>
<P>This updates the review "Glutamine supplementation for young infants with severe gastrointestinal disease" published in The Cochrane Database of Systematic Reviews (<LINK REF="REF-Grover-2007" TYPE="REFERENCE">Grover 2007</LINK>).</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2010-10-05 15:34:24 -0400" MODIFIED_BY="Diane Haughton">
<DATE DAY="18" MONTH="9" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_NEW_CONCLUSIONS">
<DATE DAY="12" MONTH="10" YEAR="2006"/>
<DESCRIPTION>
<P>Substantive amendment</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT MODIFIED="2012-05-14 10:51:42 -0400" MODIFIED_BY="[Empty name]">
<INTERNAL_SOURCES MODIFIED="2012-03-29 06:17:14 -0400" MODIFIED_BY="[Empty name]">
<SOURCE MODIFIED="2012-03-29 06:17:14 -0400" MODIFIED_BY="[Empty name]">
<NAME>University of York</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES MODIFIED="2012-05-14 10:51:42 -0400" MODIFIED_BY="[Empty name]">
<SOURCE MODIFIED="2012-05-14 10:51:42 -0400" MODIFIED_BY="[Empty name]">
<NAME>National Institute for Health Research (NIHR)</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE MODIFIED="2012-04-17 21:26:59 -0400" MODIFIED_BY="[Empty name]">
<NAME>Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institutes of Health, Department of Health and Human Services</NAME>
<COUNTRY CODE="US">USA</COUNTRY>
<DESCRIPTION>
<P>Editorial support of the Cochrane Neonatal Review Group has been funded with Federal funds from the Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institutes of Health, Department of Health and Human Services, USA, under Contract No. HHSN275201100016C<BR/>
</P>
</DESCRIPTION>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2014-12-03 12:43:25 -0500" MODIFIED_BY="[Empty name]">
<SUMMARY MODIFIED="2014-11-20 21:07:09 -0500" MODIFIED_BY="[Empty name]">
<TITLE MODIFIED="2008-09-18 11:03:06 -0400" MODIFIED_BY="[Empty name]">Glutamine supplementation for young infants with severe gastrointestinal disease</TITLE>
<SUMMARY_BODY MODIFIED="2014-11-20 21:07:09 -0500" MODIFIED_BY="[Empty name]">
<P>Glutamine is an amino acid that helps tissues, particularly in the gastrointestinal tract, recover from damage. We looked for evidence that giving extra glutamine to young infants with severe bowel problems helps them to recover faster and more fully. At present, only three trials are available; results suggest that supplemental glutamine has no benefit for these infants.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2014-11-23 22:03:10 -0500" MODIFIED_BY="[Empty name]">
<ABS_BACKGROUND MODIFIED="2014-11-23 22:02:21 -0500" MODIFIED_BY="[Empty name]">
<P>Endogenous glutamine biosynthesis may be insufficient to meet the needs of people with severe gastrointestinal disease. Results from studies using experimental animal models of gastrointestinal disease have suggested that glutamine supplementation improves clinical outcomes. This review examines evidence on the effect of glutamine supplementation in young infants with severe gastrointestinal disease.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2014-11-20 20:58:29 -0500" MODIFIED_BY="[Empty name]">
<P>To assess the effect of supplemental glutamine on mortality and morbidity in young infants with severe gastrointestinal disease.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2014-11-20 21:00:44 -0500" MODIFIED_BY="[Empty name]">
<P>We searcheed the Cochrane Central Register of Controlled Trials (<I>The Cochrane Library</I>, 2014, Issue 8), MEDLINE, EMBASE, and CINAHL (from inception to September 2014), conference proceedings, and reference lists from previous reviews.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2012-03-29 04:04:34 -0400" MODIFIED_BY="[Empty name]">
<P>Randomised or quasi-randomised controlled trials that compared glutamine supplementation versus no glutamine supplementation in infants up to three months old (corrected for preterm birth if necessary) with severe gastrointestinal disease defined as a congenital or acquired gastrointestinal condition that is likely to necessitate providing parenteral nutrition for at least 24 hours.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2014-11-21 20:45:26 -0500" MODIFIED_BY="[Empty name]">
<P>Two review authors assessed trial eligibility and risk of bias and undertook data extraction independently. We analysed the treatment effects in the individual trials and reported the risk ratio (RR) and risk difference (RD) for dichotomous data and mean difference for continuous data, with 95% confidence intervals (CI). We used a fixed-effect model in meta-analyses and explored the potential causes of heterogeneity in sensitivity analyses.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2014-11-23 22:03:10 -0500" MODIFIED_BY="[Empty name]">
<P>We found three trials in which a total of 274 infants participated. The trials were of good methodological quality but were too small to detect clinically important effects of glutamine supplementation. Meta-analyses did not reveal a statistically significant difference in the risk of death before hospital discharge (typical RR 0.79, 95% CI 0.19 to 3.20; typical RD -0.01, 95% CI -0.05 to 0.03) or in the rate of invasive infection (typical RR 1.37, 95% CI 0.89 to 2.11; typical RD 0.08, 95% CI -0.03 to 0.18]).</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2014-10-09 11:51:01 -0400" MODIFIED_BY="[Empty name]">
<P>The available data from randomised controlled trials do not suggest that glutamine supplementation has any important benefits for young infants with severe gastrointestinal disease.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2014-11-23 20:22:13 -0500" MODIFIED_BY="[Empty name]">
<BACKGROUND MODIFIED="2014-11-21 20:44:33 -0500" MODIFIED_BY="[Empty name]">
<CONDITION MODIFIED="2014-11-20 21:13:11 -0500" MODIFIED_BY="[Empty name]">
<P>Severe gastrointestinal disease - including acute necrotising enterocolitis (NEC), spontaneous localised intestinal perforation, congenital gut anomalies and atresias, anterior abdominal wall defects, Hirschsprung's disease, and acute malrotation or volvulus - is an important cause of morbidity, mortality and neuro-disability in newborn and young infants (<LINK REF="REF-Kays-1996" TYPE="REFERENCE">Kays 1996</LINK>; <LINK REF="REF-Hajivassiliou-2003" TYPE="REFERENCE">Hajivassiliou 2003</LINK>). Infants with severe gastrointestinal disease experience more episodes of invasive infection, have lower levels of nutrient intake, grow more slowly, and have longer duration of intensive care and hospital stay than gestation-comparable infants without gastrointestinal disease (<LINK REF="REF-Dalla-Vecchia-1998" TYPE="REFERENCE">Dalla Vecchia 1998</LINK>; <LINK REF="REF-Donnell-2002" TYPE="REFERENCE">Donnell 2002</LINK>; <LINK REF="REF-Abdullah-2007" TYPE="REFERENCE">Abdullah 2007</LINK>). Severe NEC, especially if treated surgically, is associated with a higher rate of long-term neurological disability, which may be a consequence of infection and under-nutrition during a critical period of brain development (<LINK REF="REF-Stoll-2004" TYPE="REFERENCE">Stoll 2004</LINK>; <LINK REF="REF-Rees-2007" TYPE="REFERENCE">Rees 2007</LINK>).</P>
</CONDITION>
<INTERVENTION MODIFIED="2014-11-20 21:33:22 -0500" MODIFIED_BY="[Empty name]">
<P>Glutamine is a key source of energy for rapidly dividing cells such as enterocytes, lymphocytes, macrophages, and neutrophils (<LINK REF="REF-Windmueller-1980" TYPE="REFERENCE">Windmueller 1980</LINK>; <LINK REF="REF-Newsholme-1999" TYPE="REFERENCE">Newsholme 1999</LINK>). Although glutamine can be synthesised in vivo, it is considered a 'conditionally essential' amino acid in catabolic states, where demand outstrips supply (<LINK REF="REF-Lacey-1990" TYPE="REFERENCE">Lacey 1990</LINK>). Plasma glutamine levels fall during critical illness or following major surgery and glutamine deficiency may limit tissue recovery in these situations (<LINK REF="REF-Parry_x002d_Billings-1990" TYPE="REFERENCE">Parry-Billings 1990</LINK>; <LINK REF="REF-Parry_x002d_Billings-1992" TYPE="REFERENCE">Parry-Billings 1992</LINK>; <LINK REF="REF-Newsholme-2001" TYPE="REFERENCE">Newsholme 2001</LINK>). While glutamine is present in human breast milk, infant formula is low in glutamine, and standard parenteral nutrition solutions contain no glutamine because it is not stable in an aqueous environment (<LINK REF="REF-Khan-1991" TYPE="REFERENCE">Khan 1991</LINK>; <LINK REF="REF-Agostini-2000" TYPE="REFERENCE">Agostini 2000</LINK>). Thus, infants who have severe gastrointestinal disease or who are recovering from major gastrointestinal surgery are unlikely to receive sufficient glutamine. Synthetic glutamine-containing dipeptides that are stable in aqueous solution are available, however (<LINK REF="REF-Furst-1997" TYPE="REFERENCE">Furst 1997</LINK>). It is therefore feasible to provide supplemental glutamine to infants with these conditions. </P>
<P>In theory, glutamine supplementation may confer several benefits to young infants with severe gastrointestinal disease. Accelerating anastomosis and wound healing and enhancing gut mucosal integrity might help infants to tolerate enteral feeding earlier and thereby shorten their duration of hospitalisation. In fact, improving gut barrier function and lymphocyte production may reduce the rate of acquired infection, lower mortality, and in the longer term, lower rates of adverse neurodevelopmental outcomes.</P>
</INTERVENTION>
<THEORY MODIFIED="2014-11-21 20:44:33 -0500" MODIFIED_BY="[Empty name]">
<P>In experimental animal models of enterocolitis, providing supplemental glutamine aided gut recovery, probably by providing additional energy for enterocyte division and proliferation (<LINK REF="REF-Klimberg-1990" TYPE="REFERENCE">Klimberg 1990</LINK>; <LINK REF="REF-Rombeau-1990" TYPE="REFERENCE">Rombeau 1990</LINK>). Peri- or postoperative glutamine supplementation may also accelerate bowel anastomosis healing (<LINK REF="REF-McCauley-1991" TYPE="REFERENCE">McCauley 1991</LINK>; <LINK REF="REF-da-Costa-2003" TYPE="REFERENCE">da Costa 2003</LINK>). In adult surgical or critically ill patients, some evidence exists that glutamine supplementation preserves gut mucosal integrity and reduces infectious complications and (possibly) mortality (<LINK REF="REF-Van-der-Hulst-1993" TYPE="REFERENCE">Van der Hulst 1993</LINK>; <LINK REF="REF-Novak-2002" TYPE="REFERENCE">Novak 2002</LINK>; <LINK REF="REF-Estivariz-2008" TYPE="REFERENCE">Estivariz 2008</LINK>). However, concerns about trial quality and publication bias have limited the reliability and applicability of these findings (<LINK REF="REF-Avenell-2009" TYPE="REFERENCE">Avenell 2009</LINK>; <LINK REF="REF-Murray-2009" TYPE="REFERENCE">Murray 2009</LINK>). More recent, larger and better quality trials have failed to demonstrate clinically important benefits of glutamine supplementation in this population (<LINK REF="REF-Andrews-2011" TYPE="REFERENCE">Andrews 2011</LINK>).</P>
<P>There is a theoretical concern that supplemental glutamine, via its metabolic products glutamate and ammonia, may have adverse neurological effects in high concentrations (<LINK REF="REF-Garlick-2001" TYPE="REFERENCE">Garlick 2001</LINK>). However, metabolic studies in preterm infants have found that parenteral glutamine supplementation (up to 0.6 g/kg/day) limits whole body proteolysis without increasing plasma amino acid or ammonia levels (<LINK REF="REF-Kalhan-2005" TYPE="REFERENCE">Kalhan 2005</LINK>). Enterally administered glutamine is metabolised entirely in the splanchnic compartment and does not affect whole-body ammonia or urea nitrogen levels (<LINK REF="REF-Parimi-2004" TYPE="REFERENCE">Parimi 2004</LINK>). Systematic reviews have not found evidence of adverse effects of glutamine supplementation in adults or in clinically stable preterm infants (<LINK REF="REF-Novak-2002" TYPE="REFERENCE">Novak 2002</LINK>; <LINK REF="REF-Avenell-2009" TYPE="REFERENCE">Avenell 2009</LINK>; <LINK REF="REF-Murray-2009" TYPE="REFERENCE">Murray 2009</LINK>; <LINK REF="REF-Moe_x002d_Byrne-2012" TYPE="REFERENCE">Moe-Byrne 2012</LINK>).</P>
</THEORY>
<IMPORTANCE MODIFIED="2014-11-20 21:38:08 -0500" MODIFIED_BY="[Empty name]">
<P>A previous Cochrane review on routine glutamine supplementation for preterm infants concluded that there is no evidence of any benefits or harms (<LINK REF="REF-Moe_x002d_Byrne-2012" TYPE="REFERENCE">Moe-Byrne 2012</LINK>). Although the infants who participated in these trials were all of very low birth weight, most were clinically stable. Any putative benefits of glutamine supplementation might be confined to critically ill infants for whom glutamine availability is rate-limiting for tissue repair, for example, infants with severe gastrointestinal disease such as NEC or infants who have undergone major gastrointestinal surgery (<LINK REF="REF-Pierro-2002" TYPE="REFERENCE">Pierro 2002</LINK>).</P>
</IMPORTANCE>
</BACKGROUND>
<OBJECTIVES MODIFIED="2014-11-20 21:42:41 -0500" MODIFIED_BY="[Empty name]">
<P>To determine whether supplemental glutamine for infants with severe gastrointestinal disease reduces mortality, decreases the time taken to establish enteral feeding, reduces the incidence of late-onset invasive infection, shortens the duration of hospitalisation, increases growth rates, and prevents adverse neurodevelopmental outcomes.</P>
</OBJECTIVES>
<METHODS MODIFIED="2014-11-21 20:46:51 -0500" MODIFIED_BY="[Empty name]">
<SELECTION_CRITERIA MODIFIED="2014-11-21 20:28:12 -0500" MODIFIED_BY="[Empty name]">
<CRIT_STUDIES>
<P>Controlled trials using either random or quasi-random patient allocation.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2014-11-21 20:25:18 -0500" MODIFIED_BY="[Empty name]">
<P>Newborn and young infants (up to and including three months old, corrected for preterm birth) with severe gastrointestinal disease defined as a congenital or acquired gastrointestinal condition that is likely to necessitate parenteral nutrition; for example, NEC, anterior abdominal wall defect, or intestinal obstruction. Infants should have been enrolled to participate in the trial within one week after gastrointestinal surgery or after the onset of NEC (if treated non-surgically).</P>
<P>NEC should have been diagnosed using Bell's criteria or modifications, that is, the presence of at least two of the following features: pneumatosis coli on abdominal radiograph; abdominal distension or abdominal radiograph with gaseous distension or frothy appearance of bowel lumen (or both); blood in stool; and lethargy, hypotonia, or apnoea, or combination of these (<LINK REF="REF-Bell-1978" TYPE="REFERENCE">Bell 1978</LINK>; <LINK REF="REF-Walsh-1986" TYPE="REFERENCE">Walsh 1986</LINK>).</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2012-03-29 04:12:16 -0400" MODIFIED_BY="[Empty name]">
<P>Glutamine supplementation versus no supplementation or placebo by the parenteral or enteral route. We did not pre-specify a minimum duration of intervention.</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2014-11-21 20:28:12 -0500" MODIFIED_BY="[Empty name]">
<CRIT_OUTCOMES_PRIMARY MODIFIED="2014-11-21 20:28:12 -0500" MODIFIED_BY="[Empty name]">
<OL>
<LI>Death prior to hospital discharge.</LI>
<LI>Neurodevelopmental outcomes assessed beyond infancy (neurological evaluations, developmental scores, and classifications of disability including auditory and visual disability, non-ambulant cerebral palsy, and developmental delay) and cognitive and educational outcomes (intelligence quotient and/or indices of educational achievement measured using a validated tool, including school examination results).</LI>
</OL>
</CRIT_OUTCOMES_PRIMARY>
<CRIT_OUTCOMES_SECONDARY MODIFIED="2012-05-14 10:53:03 -0400" MODIFIED_BY="[Empty name]">
<OL>
<LI>Time from trial entry to establish full enteral feeds independent of parenteral fluids or nutrition.</LI>
<LI>Incidence of invasive infection during hospital admission as determined by culture of bacteria or fungus from blood, cerebrospinal fluid, urine, or from a normally sterile body space (number of participants per group with one or more episodes).</LI>
<LI>Time from trial entry to discharge from hospital.</LI>
<LI>Growth during the trial period: weight gain (g/day or g/kg/day), linear growth (mm/week), head growth (mm/week), and skinfold thickness growth (mm/week).</LI>
</OL>
</CRIT_OUTCOMES_SECONDARY>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2014-11-21 20:46:31 -0500" MODIFIED_BY="[Empty name]">
<P>We used the standard search strategy of the Cochrane Neonatal Review Group.</P>
<ELECTRONIC_SEARCHES MODIFIED="2014-11-21 20:46:31 -0500" MODIFIED_BY="[Empty name]">
<P>An update search was carried out in September 2014 to locate randomised controlled trials of glutamine supplementation in surgical infants since the date of the last search in November 2011.</P>
<P>We searched the Cochrane Central Register of Controlled Trials (CENTRAL) (Wiley), EMBASE (OvidSP), Maternity and Infant Care (OvidSP), MEDLINE &amp; MEDLINE in process (OvidSP) and PubMed. We limited the searches to references added to the databases since November 2011. We limited retrieval to clinical trials using a search filter where possible. We did not apply language restrictions.</P>
<P>We searched for ongoing and completed trials in ClinicalTrials.gov, metaRegister of Controlled Trials (mRCT), and the World Health Orgainzation International Clinical Trials Registry Platform (ICTRP), limiting where possible to trials added or updated since November 2011.</P>
<P>Full search strategies with results can be found in <LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>.</P>
</ELECTRONIC_SEARCHES>
<OTHER_SEARCHES MODIFIED="2014-11-21 20:36:24 -0500" MODIFIED_BY="[Empty name]">
<P>We examined the reference lists of studies identified as potentially relevant. We searched the abstracts from the annual meetings of the Pediatric Academic Societies (1993 to 2014), the European Society for Paediatric Research (1995 to 2013), the UK Royal College of Paediatrics and Child Health (2000 to 2014), and the Perinatal Society of Australia and New Zealand (2000 to 2014). We considered trials reported only as abstracts to be eligible if sufficient information was available from the report, or from contact with the authors, to fulfil the inclusion criteria.</P>
</OTHER_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2014-11-21 20:46:51 -0500" MODIFIED_BY="[Empty name]">
<P>We used the standard methods of the Cochrane Neonatal Review Group.</P>
<STUDY_SELECTION MODIFIED="2012-03-01 06:40:26 -0500" MODIFIED_BY="Jennifer V E Wagner">
<P>Two review authors screened the title and abstract of all studies identified by the above search strategy. We assessed the full text of any potentially eligible reports and excluded those studies that did not meet all of the inclusion criteria. We discussed any disagreements until consensus was achieved.<BR/>
</P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2014-10-09 11:59:44 -0400" MODIFIED_BY="[Empty name]">
<P>We used a data collection form to aid extraction of relevant information from each included study. Two review authors extracted the data separately. We discussed any disagreements until consensus was achieved. We asked the investigators for further information if data from the trial reports were insufficient.</P>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2012-05-14 10:42:18 -0400" MODIFIED_BY="Jennifer V E Wagner">
<P>We used the criteria and standard methods of the Cochrane Neonatal Review Group to assess the methodological quality of any included trials. Additional information from the trial authors was requested to clarify methodology and results as necessary. We evaluated and reported the following issues in the 'Risk of bias' tables.</P>
<OL>
<LI>Sequence generation: we categorised the method used to generate the allocation sequence as:</LI>
<OL>
<LI>low risk: any random process (e.g. random number table; computer random number generator);</LI>
<LI>high risk: any non-random process (e.g. odd or even date of birth; patient case-record number);</LI>
<LI>unclear.</LI>
</OL>
<LI>Allocation concealment: we categorised the method used to conceal the allocation sequence as:</LI>
<OL>
<LI>low risk: (e.g. telephone or central randomisation; consecutively numbered sealed opaque envelopes);</LI>
<LI>high risk: open random allocation; unsealed or non-opaque envelopes, alternation; date of birth;</LI>
<LI>unclear.</LI>
</OL>
<LI>Blinding: we assessed blinding of participants, clinicians and carers, and outcome assessors separately for different outcomes and categorised the methods as:</LI>
<OL>
<LI>low risk;</LI>
<LI>high risk;</LI>
<LI>unclear.</LI>
</OL>
<LI>Incomplete outcome data: we described the completeness of data including attrition and exclusions from the analysis for each outcome and any reasons for attrition or exclusion where reported. We assessed whether missing data were balanced across groups or were related to outcomes. Where sufficient information was reported or supplied by the trial authors, we re-included missing data in the analyses. We categorised completeness as:</LI>
<OL>
<LI>low risk: &lt; 20% missing data;</LI>
<LI>high risk: &#8805; 20% missing data;</LI>
<LI>unclear.</LI>
</OL>
</OL>
</QUALITY_ASSESSMENT>
<EFFECT_MEASURES MODIFIED="2012-05-14 10:42:23 -0400" MODIFIED_BY="Jennifer V E Wagner">
<P>We calculated risk ratio (RR) and risk difference (RD) for dichotomous data and weighted mean difference (WMD) for continuous data with respective 95% confidence intervals (CI). We determined the number needed to treat for benefit (NNTB) or harm (NNTH) for a statistically significant difference in the RD.<BR/>
</P>
</EFFECT_MEASURES>
<UNIT_OF_ANALYSIS MODIFIED="2012-03-01 06:50:08 -0500" MODIFIED_BY="Jennifer V E Wagner">
<P>The unit of analysis is the participating infant in individually randomised trials and the neonatal unit for cluster randomised trials.</P>
</UNIT_OF_ANALYSIS>
<MISSING_DATA MODIFIED="2012-03-29 04:17:32 -0400" MODIFIED_BY="Jennifer V E Wagner">
<P>We requested missing study data from the trial investigators.</P>
</MISSING_DATA>
<HETEROGENEITY_ASSESSMENT MODIFIED="2014-10-09 12:03:51 -0400" MODIFIED_BY="Jennifer V E Wagner">
<P>If more than one trial was included in a meta-analysis, we examined the treatment effects of individual trials and heterogeneity between trial results by inspecting the forest plots. We calculated the I² statistic for each analysis to quantify inconsistency across studies and describe the percentage of variability in effect estimates that may be due to heterogeneity rather than sampling error. If substantial (I² &gt; 50%) heterogeneity was detected, we explored the possible causes (for example, differences in study design, participants, interventions, or completeness of outcome assessments) in sensitivity analyses.</P>
</HETEROGENEITY_ASSESSMENT>
<DATA_SYNTHESIS MODIFIED="2014-11-21 20:46:51 -0500" MODIFIED_BY="[Empty name]">
<P>We used a fixed-effect model for meta-analyses.</P>
</DATA_SYNTHESIS>
<SUBGROUP_ANALYSIS MODIFIED="2014-11-21 20:43:08 -0500" MODIFIED_BY="[Empty name]">
<P>We pre-specified the following subgroup analyses:</P>
<OL>
<LI>trials where participants were predominantly (&gt; 80%) term infants versus trials where participants were predominantly preterm infants;</LI>
<LI>trials where participants were infants with NEC versus trials where participants were infants who had undergone gastrointestinal surgery for other indications;</LI>
<LI>trials where infants received enteral glutamine supplementation versus trials where supplemental glutamine was given parenterally;</LI>
<LI>trials where the aim was to give at least 0.2 g/kg/day of glutamine versus trials where less glutamine supplementation was given.</LI>
</OL>
</SUBGROUP_ANALYSIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2014-11-23 20:05:30 -0500" MODIFIED_BY="[Empty name]">
<STUDY_DESCRIPTION MODIFIED="2014-11-23 19:55:44 -0500" MODIFIED_BY="[Empty name]">
<P>See <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>; <LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK>.</P>
<SEARCH_RESULTS MODIFIED="2014-11-21 20:48:02 -0500" MODIFIED_BY="[Empty name]">
<P>We have included a trial previously identified as ongoing in this review update (<LINK REF="STD-Ong-2012" TYPE="STUDY">Ong 2012</LINK>). The status of <LINK REF="STD-NCT00647036" TYPE="STUDY">NCT00647036</LINK>, which was also identified as ongoing in 2011, is not known.</P>
<P>Three trials, in which a total of 274 infants participated, fulfilled eligibility criteria (<LINK REF="STD-Duggan-2004" TYPE="STUDY">Duggan 2004</LINK>; <LINK REF="STD-Albers-2005" TYPE="STUDY">Albers 2005</LINK>, <LINK REF="STD-Ong-2012" TYPE="STUDY">Ong 2012</LINK>). The abstract of another small trial (n = 13) was found by our searches in 2011 (<LINK REF="REF-Nolin-2001" TYPE="REFERENCE">Nolin 2001</LINK>). Further searching in September 2014 identified the full-text of a master's thesis (<LINK REF="STD-Nolin-2000" TYPE="STUDY">Nolin 2000</LINK>). As this study did not focus on infants undergoing gastrointestinal surgery we have now excluded it from this review.</P>
</SEARCH_RESULTS>
<INCLUDED_STUDIES_DESCR MODIFIED="2014-11-23 19:48:36 -0500" MODIFIED_BY="[Empty name]">
<P>Two trials were single-centre studies undertaken in surgical neonatal and paediatric intensive care centres in Europe (<LINK REF="STD-Albers-2005" TYPE="STUDY">Albers 2005</LINK>) and North America (<LINK REF="STD-Duggan-2004" TYPE="STUDY">Duggan 2004</LINK>). The third trial was conducted in 14 paediatric surgical units across the UK (<LINK REF="STD-Ong-2012" TYPE="STUDY">Ong 2012</LINK>). All participants were recruited between 2000 and 2005. The smallest trial was a pilot study that aimed to assess feasibility and safety (<LINK REF="STD-Duggan-2004" TYPE="STUDY">Duggan 2004</LINK>).</P>
<SUBSECTION>
<HEADING LEVEL="4">Participants</HEADING>
<P>
<LINK REF="STD-Duggan-2004" TYPE="STUDY">Duggan 2004</LINK> enrolled 20 young infants with severe gastrointestinal diseases (NEC, intestinal atresia, or anterior abdominal wall defects). Most participants were preterm (average gestational age at birth 33 weeks). Their median postnatal age at enrolment was 15 days.</P>
<P>
<LINK REF="STD-Albers-2005" TYPE="STUDY">Albers 2005</LINK> enrolled 80 children of gestational age at birth &gt; 30 weeks and chronological age less than two years. This trial, therefore, did not strictly fulfil our a priori population criterion (infants &lt; 3 months old). However, we decided to include the trial because the report stated that most (69 of the 80) participants were less than six months old at enrolment. The report did not provide subgroup data for infants less than three months old. The most common gastrointestinal conditions affecting participants were NEC, congenital bowel atresia or obstruction, anterior abdominal wall defects, and Hirschsprung's disease. Infants were not expected to be able to tolerate enteral nutrition for at least four days following gastrointestinal tract surgery. The median postnatal age at enrolment was 11 days.</P>
<P>
<LINK REF="STD-Ong-2012" TYPE="STUDY">Ong 2012</LINK> enrolled 174 young infants with severe gastrointestinal diseases (abdominal wall defect, congenital bowel obstruction, or NEC). Most participants were born at term (median gestational age at birth 37 weeks). Their median postnatal age at enrolment was five days.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Interventions</HEADING>
<P>
<LINK REF="STD-Duggan-2004" TYPE="STUDY">Duggan 2004</LINK>: When judged by the attending clinicians to be ready to tolerate the introduction of enteral feeds, participating infants were randomly allocated to either glutamine-supplemented expressed human milk or hydrolysed formula milk versus human milk or formula without added glutamine (but with an iso-osmolar mix of non-essential amino acids). The glutamine-supplemented and non-supplemented milks were indistinguishable to the parents, carers, and assessors. The intervention group received 0.08 g/kg/day of glutamine at the start of the study. This increased to 0.31 g/kg/day by two weeks post enrolment. Glutamine supplementation was stopped on day 30. All infants received the same level of parenteral nutrition (without added glutamine) while enteral feeds were being advanced.</P>
<P>
<LINK REF="STD-Albers-2005" TYPE="STUDY">Albers 2005</LINK>: On the second postoperative day, infants in the intervention group received a standard parenteral nutrition solution supplemented with L-glutamine sufficient to provide 0.4 g/kg/day. Control infants received parenteral nutrition with an iso-nitrogenous amino acid solution. The carers were not aware whether participating infants received glutamine-supplemented or non-supplemented parenteral nutrition. The protocol specified that participating infants should continue to receive full parenteral nutrition until at least the sixth postoperative day when enteral feeding was gradually re-introduced.</P>
<P>
<LINK REF="STD-Ong-2012" TYPE="STUDY">Ong 2012</LINK>: From day three of parenteral nutrition, infants in the intervention group received a glutamine dipeptide supplement providing 0.4 g/kg/day of glutamine. This was continued while parenteral nutrition was administered. The control group received an isonitrogenous, isocaloric parenteral nutrition solution. The solutions were indistinguishable to parents, carers, and assessors, and nutritional information on labels did not allow identification of the solution. All study participants received only parenteral nutrition at the start of the trial and were gradually progressed to full enteral feeds. While exclusively receiving parenteral nutrition the control group did not receive any glutamine. With the introduction of enteral feeds, the control group received some naturally occurring glutamine in breast milk or formula.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Outcomes</HEADING>
<P>
<LINK REF="STD-Duggan-2004" TYPE="STUDY">Duggan 2004</LINK> assessed the effect of enteral glutamine supplementation on the time taken to establish full enteral feeding, rates of nosocomial infection, and growth during the study period.</P>
<P>
<LINK REF="STD-Albers-2005" TYPE="STUDY">Albers 2005</LINK> assessed the effect of parenteral glutamine supplementation on intestinal permeability (urinary excretion ratios of lactulose and rhamnose) and nitrogen balance. Mortality, duration of intensive care stay, and rates of nosocomial infection were reported as secondary outcomes.</P>
<P>
<LINK REF="STD-Ong-2012" TYPE="STUDY">Ong 2012</LINK> assessed the effect of parenteral glutamine supplementation on time required to achieve full enteral nutrition and the incidence of "sepsis" and "septicaemia". Adverse events and mortality were also reported.</P>
</SUBSECTION>
</INCLUDED_STUDIES_DESCR>
<EXCLUDED_STUDIES_DESCR MODIFIED="2014-11-23 19:55:44 -0500" MODIFIED_BY="[Empty name]">
<P>Three trials that appeared potentially eligible were excluded after further evaluation of the full report (<LINK REF="STD-Barbosa-1999" TYPE="STUDY">Barbosa 1999</LINK>; <LINK REF="STD-Nolin-2000" TYPE="STUDY">Nolin 2000</LINK>, <LINK REF="STD-Ehrenkranz-2011" TYPE="STUDY">Ehrenkranz 2011</LINK>). Most participants in these trials were infants with non-gastrointestinal disease.</P>
</EXCLUDED_STUDIES_DESCR>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2014-10-09 12:08:54 -0400" MODIFIED_BY="[Empty name]">
<P>The overall methodological quality of all studies was good.</P>
<ALLOCATION MODIFIED="2014-10-09 12:08:47 -0400" MODIFIED_BY="[Empty name]">
<P>All trials used methods to conceal allocation.</P>
</ALLOCATION>
<BLINDING MODIFIED="2014-10-09 12:08:50 -0400" MODIFIED_BY="[Empty name]">
<P>All trials blinded carers and assessors to the intervention.</P>
</BLINDING>
<EXCLUSIONS MODIFIED="2014-10-09 12:08:54 -0400" MODIFIED_BY="[Empty name]">
<P>All trials achieved complete or near-complete follow-up.</P>
</EXCLUSIONS>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2014-11-23 20:05:30 -0500" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="3">Glutamine supplementation (parenteral or enteral) versus no supplementation</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Mortality prior to hospital discharge (Outcome 1.1):</HEADING>
<P>None of the trials nor a meta-analysis of data from all trials showed a statistically significant difference in mortality (typical RR 0.79, 95% CI 0.19 to 3.20; typical RD -0.01, 95% CI -0.05 to 0.03). (<LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>; <LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Neurodevelopmental outcomes</HEADING>
<P>This outcome was not assessed in any trial.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Incidence of invasive infection (Outcome 1.2)</HEADING>
<P>None of the trials nor a meta-analysis of data from both trials showed a statistically significant difference in infection rates (typical RR 1.37, 95% CI 0.89 to 2.11; typical RD 0.08, 95% CI -0.03 to 0.18). (<LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>; <LINK REF="CMP-001.02" TYPE="ANALYSIS">Analysis 1.2</LINK>)</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Time to establish full enteral feeds</HEADING>
<P>
<LINK REF="STD-Duggan-2004" TYPE="STUDY">Duggan 2004</LINK> reported no statistically significant difference in the time taken to establish full enteral feeding in the intervention group (median 39 days; interquartile range 12 to 99) versus the control group (median 21 days; interquartile range 6 to 59). Similarly, <LINK REF="STD-Ong-2012" TYPE="STUDY">Ong 2012</LINK> reported that there was no statistically significant difference in the time taken to establish full enteral feeds between the intervention group (median: 19 days; 5th to 95th centile 14.6 to 23.4) and the control group (median: 16 days; 5th to 95th centile 13.6 to 18.4). <LINK REF="STD-Albers-2005" TYPE="STUDY">Albers 2005</LINK> did not report on this outcome.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Time to discharge from hospital</HEADING>
<P>
<LINK REF="STD-Albers-2005" TYPE="STUDY">Albers 2005</LINK> did not find a statistically significant difference between the intervention group (median 32 days; interquartile range 16.8 to 44.8) and the control group (median 31.5 days; interquartile range 14 to 64). <LINK REF="STD-Duggan-2004" TYPE="STUDY">Duggan 2004</LINK> did not assess time to hospital discharge (according to personal communication from trial authors). Time to discharge was not reported by <LINK REF="STD-Ong-2012" TYPE="STUDY">Ong 2012</LINK>.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Growth during the trial period</HEADING>
<P>
<LINK REF="STD-Duggan-2004" TYPE="STUDY">Duggan 2004</LINK> did not find a statistically significant difference in the rate of weight gain during the study period (MD 3.80 g/day; 95% CI -6.65 to 14.25) (<LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK>; <LINK REF="CMP-001.03" TYPE="ANALYSIS">Analysis 1.3</LINK>). The report also stated that there was not a statistically significant difference in the rate of change in length or 'arm anthropometrics' but data were not presented. <LINK REF="STD-Ong-2012" TYPE="STUDY">Ong 2012</LINK> reported no significant difference in weight centile change between groups and maintenance of head circumference centiles in each group. Data were not presented. <LINK REF="STD-Albers-2005" TYPE="STUDY">Albers 2005</LINK> did not report growth during the trial period.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Subgroup analyses</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Trials where participants were predominantly term infants versus trials where participants were predominantly preterm infants</HEADING>
<P>
<LINK REF="STD-Duggan-2004" TYPE="STUDY">Duggan 2004</LINK> recruited preterm infants predominantly - see above. For <LINK REF="STD-Albers-2005" TYPE="STUDY">Albers 2005</LINK> and <LINK REF="STD-Ong-2012" TYPE="STUDY">Ong 2012</LINK>, subgroup data were not available.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Trials where participants were infants with NEC versus trials where participants were infants who had undergone gastrointestinal surgery for other indications</HEADING>
<P>In <LINK REF="STD-Albers-2005" TYPE="STUDY">Albers 2005</LINK>, 19 of 80 participating infants had NEC. In <LINK REF="STD-Duggan-2004" TYPE="STUDY">Duggan 2004</LINK>, eight of 20 participating infants had NEC. In <LINK REF="STD-Ong-2012" TYPE="STUDY">Ong 2012</LINK>, seven of 174 participating infants had NEC. Subgroup data for infants with NEC versus other surgical gastrointestinal conditions were not presented in any of the reports.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Trials where infants received enteral glutamine supplementation versus no supplementation and trials where supplemental glutamine was given parenterally versus no supplementation</HEADING>
<P>
<LINK REF="STD-Albers-2005" TYPE="STUDY">Albers 2005</LINK> and <LINK REF="STD-Ong-2012" TYPE="STUDY">Ong 2012</LINK> studied the effect of parenteral glutamine supplementation - see above. <LINK REF="STD-Duggan-2004" TYPE="STUDY">Duggan 2004</LINK> studied the effect of enteral glutamine supplementation - see above.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Trials where the aim was to give at least 0.2 g/kg/day of glutamine versus trials where less glutamine supplementation was given</HEADING>
<P>All trials aimed to provide at least 0.2 g/kg/day on average of glutamine.</P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2014-11-23 20:18:46 -0500" MODIFIED_BY="[Empty name]">
<SUMMARY_OF_RESULTS MODIFIED="2014-11-23 20:10:27 -0500" MODIFIED_BY="[Empty name]">
<P>Three good quality randomised controlled trials in which 274 infants with severe gastrointestinal disease participated assessed the effect of glutamine supplementation versus no glutamine. The available data do not provide evidence that supplemental glutamine affects mortality, rates of invasive infection, or other morbidity.</P>
</SUMMARY_OF_RESULTS>
<APPLICABILITY_OF_FINDINGS MODIFIED="2014-11-23 20:18:46 -0500" MODIFIED_BY="[Empty name]">
<P>Although methodologically sound, the included trials were too small to detect moderate but potentially important effects on the specified outcomes of this review. Based on a control event rate for invasive infection (consistent with the included trials), a single trial would need to enrol about 2500 participants (1250 in each group) to be able to detect a 25% risk reduction with 5% significance and 90% power. This optimum study size is an order of magnitude larger than the total number of participants in the trials identified in this review.</P>
<P>Furthermore, the included trials recruited a heterogeneous group of participants with a range of severe gastrointestinal diseases. This heterogeneity may limit meaningful evaluation of the effect of glutamine supplementation. For example, the effect of glutamine supplementation may be different for sick, very preterm infants recovering from severe NEC compared with term infants who have had reduction of an anterior abdominal wall defect but are otherwise metabolically and physiologically stable. If further data become available from ongoing trials, subgroup analyses by gestational age at birth (term versus preterm) or by type of gastrointestinal disease may be needed to define which groups of infants, if any, benefit from glutamine supplementation.</P>
<P>Variation in the route of administration of supplemental glutamine (enteral versus parenteral) is also a potentially important source of trial heterogeneity that may affect outcomes. Systematic review of trials in adults suggests that parenteral supplementation confers more clinical benefits than enteral supplementation (<LINK REF="REF-Novak-2002" TYPE="REFERENCE">Novak 2002</LINK>). However, laboratory studies have suggested that using the enteral route results in a much higher concentration of free glutamine being delivered to the intestinal mucosa and that this reduces bacterial translocation and invasive infection (<LINK REF="REF-Panigrahi-1997" TYPE="REFERENCE">Panigrahi 1997</LINK>). The theoretical disadvantage to enteral administration is that glutamine is metabolised entirely in the splanchnic compartment with no net increase in free glutamine delivery to other organs (<LINK REF="REF-Parimi-2004" TYPE="REFERENCE">Parimi 2004</LINK>). The most appropriate route of delivery may also be affected by the underlying gastrointestinal condition. For example, it may not be possible to deliver enteral glutamine to very preterm infants with severe NEC, but this may be the most appropriate route for clinically stable infants recovering from a less physiologically destabilising gastrointestinal condition.</P>
</APPLICABILITY_OF_FINDINGS>
<QUALITY_OF_EVIDENCE MODIFIED="2014-10-09 12:15:21 -0400" MODIFIED_BY="[Empty name]">
<P>All three trials were of good methodological quality but were too small to detect moderate but potentially important effects (<LINK REF="STD-Duggan-2004" TYPE="STUDY">Duggan 2004</LINK>; <LINK REF="STD-Albers-2005" TYPE="STUDY">Albers 2005</LINK>, <LINK REF="STD-Ong-2012" TYPE="STUDY">Ong 2012</LINK>).</P>
</QUALITY_OF_EVIDENCE>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2014-11-23 20:22:13 -0500" MODIFIED_BY="[Empty name]">
<IMPLICATIONS_PRACTICE MODIFIED="2014-10-09 12:15:54 -0400" MODIFIED_BY="[Empty name]">
<P>The currently available evidence from three trials does not indicate that glutamine supplementation improves important clinical outcomes for young infants with severe gastrointestinal disease.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2014-11-23 20:22:13 -0500" MODIFIED_BY="[Empty name]">
<P>A very large randomised controlled trial is required to assess whether glutamine supplementation is beneficial for young infants with severe gastrointestinal disease. Future trials may also need to be of sufficient size to allow subgroup analyses by type of gastrointestinal disease and by gestational age.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2014-12-03 12:43:25 -0500" MODIFIED_BY="[Empty name]">
<P>We thank Mellisa Harden (Centre for Reviews and Dissemination, University of York) for revising and running the electronic search.</P>
<P>We thank Professor Christopher Duggan for supporting a previous version of this review by providing further details about his trial (<LINK REF="STD-Duggan-2004" TYPE="STUDY">Duggan 2004</LINK>), Professor Satish Kalhan for sharing data and for advising on glutamine metabolic studies in young infants, and Drs. Tubman and Zubin Grover for contributing to a previous iteration (<LINK REF="REF-Grover-2007" TYPE="REFERENCE">Grover 2007</LINK>).</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST>
<P>None.</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2014-10-09 07:02:30 -0400" MODIFIED_BY="[Empty name]">
<P>In discussion with WM, JVEB searched and screened the studies for inclusion, assessed the methodological quality of the trials, and extracted and entered the relevant information and data from each included study. WM and JVEB completed the final review.<BR/>
</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF MODIFIED="2014-12-03 12:19:22 -0500" MODIFIED_BY="[Empty name]">
<P>
<LINK REF="STD-Albers-2005" TYPE="STUDY">Albers 2005</LINK> enrolled 80 children of gestational age at birth &gt; 30 weeks and chronological age less than two years. This trial therefore did not strictly fulfil our a priori population criterion (infants up to three months old). However, we decided to include the trial because the report stated that most (69 of the 80) participants were less than six months old at enrolment. The report did not provide subgroup data for infants up to three months old.</P>
</PRO_REV_DIFF>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2014-11-23 21:50:14 -0500" MODIFIED_BY="[Empty name]">
<STUDIES MODIFIED="2014-11-16 19:55:25 -0500" MODIFIED_BY="[Empty name]">
<INCLUDED_STUDIES MODIFIED="2014-11-16 19:45:43 -0500" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Albers-2005" MODIFIED="2014-11-16 19:42:48 -0500" MODIFIED_BY="Anne Lawson" NAME="Albers 2005" YEAR="2005">
<REFERENCE MODIFIED="2014-11-16 19:42:48 -0500" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Albers MJ, Steyerberg EW, Hazebroek FW, Mourik M, Borsboom GJ, Rietveld T, et al</AU>
<TI>Glutamine supplementation of parenteral nutrition does not improve intestinal permeability, nitrogen balance, or outcome in newborns and infants undergoing digestive-tract surgery: results from a double-blind, randomized, controlled trial</TI>
<SO>Annals of Surgery</SO>
<YR>2005</YR>
<VL>241</VL>
<NO>4</NO>
<PG>599-606</PG>
<IDENTIFIERS MODIFIED="2014-11-16 19:42:48 -0500" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2014-11-16 19:42:47 -0500" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="15798461"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Duggan-2004" MODIFIED="2014-11-16 19:43:48 -0500" MODIFIED_BY="Anne Lawson" NAME="Duggan 2004" YEAR="2004">
<REFERENCE MODIFIED="2014-11-16 19:43:48 -0500" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Duggan C, Stark AR, Auestad N, Collier S, Fulhan J, Gura K, et al</AU>
<TI>Glutamine supplementation in infants with gastrointestinal disease: a randomized, placebo-controlled pilot trial</TI>
<SO>Nutrition</SO>
<YR>2004</YR>
<VL>20</VL>
<NO>9</NO>
<PG>752-6</PG>
<IDENTIFIERS MODIFIED="2014-11-16 19:43:48 -0500" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2014-11-16 19:43:48 -0500" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="15325681"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Ong-2012" MODIFIED="2014-11-16 19:45:43 -0500" MODIFIED_BY="[Empty name]" NAME="Ong 2012" YEAR="2012">
<REFERENCE MODIFIED="2014-11-16 19:45:43 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ong EG, Eaton S, Wade AM, Horn V, Losty PD, Curry JI, et al</AU>
<TI>Randomised clinical trial of glutamine-supplemented versus standard parenteral nutrition in infants with surgical gastrointestinal disease</TI>
<SO>British Journal of Surgery</SO>
<YR>2012</YR>
<VL>99</VL>
<NO>7</NO>
<PG>929-38</PG>
<IDENTIFIERS MODIFIED="2014-11-16 19:45:43 -0500" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2014-11-16 19:45:43 -0500" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/bjs.8750"/>
<IDENTIFIER MODIFIED="2014-11-16 19:45:35 -0500" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="22513659"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2014-09-30 10:13:58 -0400" MODIFIED_BY="[Empty name]"/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2014-11-16 19:49:28 -0500" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Barbosa-1999" MODIFIED="2014-11-16 19:46:31 -0500" MODIFIED_BY="Thirimon Moe Byrne" NAME="Barbosa 1999" YEAR="1999">
<REFERENCE MODIFIED="2014-11-16 19:46:31 -0500" MODIFIED_BY="Thirimon Moe Byrne" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Barbosa E, Moreira EA, Goes JE, Faintuch J</AU>
<TI>Pilot study with a glutamine-supplemented enteral formula in critically ill infants</TI>
<SO>Revista do Hospital das Clínicas</SO>
<YR>1999</YR>
<VL>54</VL>
<NO>1</NO>
<PG>21-4</PG>
<IDENTIFIERS MODIFIED="2014-11-16 19:46:31 -0500" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2014-11-16 19:46:31 -0500" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="10488597"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ehrenkranz-2011" MODIFIED="2014-11-16 19:47:35 -0500" MODIFIED_BY="Thirimon Moe Byrne" NAME="Ehrenkranz 2011" YEAR="2011">
<REFERENCE MODIFIED="2014-11-16 19:47:35 -0500" MODIFIED_BY="Thirimon Moe Byrne" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ehrenkranz RA, Das A, Wrage LA, Poindexter BB, Higgins RD, Stoll BJ, et al</AU>
<TI>Early nutrition mediates the influence of severity of illness on extremely LBW infants</TI>
<SO>Pediatric Research</SO>
<YR>2011</YR>
<VL>69</VL>
<NO>6</NO>
<PG>522-9</PG>
<IDENTIFIERS MODIFIED="2014-11-16 19:47:35 -0500" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2014-11-16 19:47:35 -0500" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1203/PDR.0b013e318217f4f1"/>
<IDENTIFIER MODIFIED="2014-11-16 19:47:29 -0500" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="21378596"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="UNPUB" ID="STD-Nolin-2000" MODIFIED="2014-11-16 19:49:28 -0500" MODIFIED_BY="[Empty name]" NAME="Nolin 2000" YEAR="2000">
<REFERENCE MODIFIED="2014-11-16 19:49:28 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="UNPUBLISHED">
<AU>Nolin F</AU>
<TI>Parenteral glutamine supplementation in neonates following surgical stress</TI>
<SO>http://digitool.library.mcgill.ca/R/?func=dbin-jump-full&amp;object_id=31281&amp;local_base=GEN01-MCG02</SO>
<YR>2000</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES MODIFIED="2014-11-16 19:55:25 -0500" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-NCT00647036" MODIFIED="2014-11-16 19:55:25 -0500" MODIFIED_BY="[Empty name]" NAME="NCT00647036" YEAR="2008">
<IDENTIFIERS MODIFIED="2014-11-16 19:55:25 -0500" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2014-11-16 19:55:25 -0500" MODIFIED_BY="[Empty name]" TYPE="CTG" VALUE="NCT00647036"/>
</IDENTIFIERS>
</STUDY>
</AWAITING_STUDIES>
<ONGOING_STUDIES MODIFIED="2014-10-09 06:19:49 -0400" MODIFIED_BY="[Empty name]"/>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2014-11-23 21:50:14 -0500" MODIFIED_BY="[Empty name]">
<ADDITIONAL_REFERENCES MODIFIED="2014-11-23 21:50:14 -0500" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Abdullah-2007" MODIFIED="2012-04-18 15:48:01 -0400" MODIFIED_BY="[Empty name]" NAME="Abdullah 2007" TYPE="JOURNAL_ARTICLE">
<AU>Abdullah F, Arnold MA, Nabaweesi R, Fischer AC, Colombani PM, Anderson KD, et al</AU>
<TI>Gastroschisis in the United States 1988-2003: analysis and risk categorization of 4344 patients</TI>
<SO>Journal of Perinatology</SO>
<YR>2007</YR>
<VL>27</VL>
<NO>1</NO>
<PG>50-5</PG>
<IDENTIFIERS MODIFIED="2012-03-29 05:41:19 -0400" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="17036030"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Agostini-2000" MODIFIED="2014-11-16 19:56:59 -0500" MODIFIED_BY="[Empty name]" NAME="Agostini 2000" TYPE="JOURNAL_ARTICLE">
<AU>Agostoni C, Carratu B, Boniglia C, Riva E, Sanzini E</AU>
<TI>Free amino acid content in standard infant formulas: comparison with human milk</TI>
<SO>Journal of the American College of Nutrition</SO>
<YR>2000</YR>
<VL>19</VL>
<NO>4</NO>
<PG>434-8</PG>
<IDENTIFIERS MODIFIED="2014-11-16 19:56:59 -0500" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2014-11-16 19:56:59 -0500" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="10963461"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Andrews-2011" MODIFIED="2014-11-16 19:58:16 -0500" MODIFIED_BY="[Empty name]" NAME="Andrews 2011" TYPE="JOURNAL_ARTICLE">
<AU>Andrews PJ, Avenell A, Noble DW, Campbell MK, Croal BL, Simpson WG, et al</AU>
<TI>Randomised trial of glutamine, selenium, or both, to supplement parenteral nutrition for critically ill patients</TI>
<SO>BMJ</SO>
<YR>2011</YR>
<VL>342</VL>
<PG>d1542</PG>
<IDENTIFIERS MODIFIED="2014-11-16 19:58:16 -0500" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2014-11-16 19:58:16 -0500" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1136/bmj.d1542"/>
<IDENTIFIER MODIFIED="2014-11-16 19:57:49 -0500" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="21415104"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Avenell-2009" MODIFIED="2014-11-16 19:59:07 -0500" MODIFIED_BY="[Empty name]" NAME="Avenell 2009" TYPE="JOURNAL_ARTICLE">
<AU>Avenell A</AU>
<TI>Hot topics in parenteral nutrition. Current evidence and ongoing trials on the use of glutamine in critically-ill patients and patients undergoing surgery</TI>
<SO>The Proceedings of the Nutrition Society</SO>
<YR>2009</YR>
<VL>68</VL>
<NO>3</NO>
<PG>261-8</PG>
<IDENTIFIERS MODIFIED="2014-11-16 19:59:07 -0500" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2014-11-16 19:59:07 -0500" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1017/S0029665109001372"/>
<IDENTIFIER TYPE="PUBMED" VALUE="19490739"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Bell-1978" MODIFIED="2014-11-16 20:00:06 -0500" MODIFIED_BY="[Empty name]" NAME="Bell 1978" TYPE="JOURNAL_ARTICLE">
<AU>Bell MJ, Ternberg JL, Feigin RD, Keating JP, Marshall R, Barton L, et al</AU>
<TI>Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging</TI>
<SO>Annals of Surgery</SO>
<YR>1978</YR>
<VL>187</VL>
<NO>1</NO>
<PG>1-7</PG>
<IDENTIFIERS MODIFIED="2014-11-16 20:00:06 -0500" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2014-11-16 20:00:06 -0500" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="413500"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-da-Costa-2003" MODIFIED="2014-11-16 20:00:57 -0500" MODIFIED_BY="[Empty name]" NAME="da Costa 2003" TYPE="JOURNAL_ARTICLE">
<AU>da Costa MA, Campos AC, Coelho JC, de Barros AM, Matsumoto HM</AU>
<TI>Oral glutamine and the healing of colonic anastomoses in rats</TI>
<SO>Journal of Parenteral and Enteral Nutrition</SO>
<YR>2003</YR>
<VL>27</VL>
<NO>3</NO>
<PG>182-5</PG>
<IDENTIFIERS MODIFIED="2014-11-16 20:00:57 -0500" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2014-11-16 20:00:57 -0500" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="12757111"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Dalla-Vecchia-1998" MODIFIED="2012-04-18 15:53:36 -0400" MODIFIED_BY="[Empty name]" NAME="Dalla Vecchia 1998" TYPE="JOURNAL_ARTICLE">
<AU>Dalla Vecchia LK, Grosfeld JL, West KW, Rescorla FJ, Scherer LR, Engum SA</AU>
<TI>Intestinal atresia and stenosis: a 25-year experience with 277 cases</TI>
<SO>Archives of Surgery</SO>
<YR>1998</YR>
<VL>133</VL>
<NO>5</NO>
<PG>490-6</PG>
<IDENTIFIERS MODIFIED="2012-03-29 05:41:19 -0400" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="9605910"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Donnell-2002" MODIFIED="2012-04-18 15:55:18 -0400" MODIFIED_BY="[Empty name]" NAME="Donnell 2002" TYPE="JOURNAL_ARTICLE">
<AU>Donnell SC, Taylor N, van Saene HK, Magnall VL, Pierro A, Lloyd DA</AU>
<TI>Infection rates in surgical neonates and infants receiving parenteral nutrition: a five-year prospective study</TI>
<SO>The Journal of Hospital Infection</SO>
<YR>2002</YR>
<VL>52</VL>
<NO>4</NO>
<PG>273-80</PG>
<IDENTIFIERS MODIFIED="2012-03-29 05:38:45 -0400" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="12473472"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Estivariz-2008" MODIFIED="2014-11-16 20:03:13 -0500" MODIFIED_BY="[Empty name]" NAME="Estivariz 2008" TYPE="JOURNAL_ARTICLE">
<AU>Estivariz CF, Griffith DP, Luo M, Szeszycki EE, Bazargan N, Dave N, et al</AU>
<TI>Efficacy of parenteral nutrition supplemented with glutamine dipeptide to decrease hospital infections in critically ill surgical patients</TI>
<SO>Journal of Parenteral and Enteral Nutrition</SO>
<YR>2008</YR>
<VL>32</VL>
<NO>4</NO>
<PG>389-402</PG>
<IDENTIFIERS MODIFIED="2014-11-16 20:03:13 -0500" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2014-11-16 20:03:13 -0500" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1177/0148607108317880"/>
<IDENTIFIER TYPE="PUBMED" VALUE="18596310"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Furst-1997" MODIFIED="2014-11-16 20:04:13 -0500" MODIFIED_BY="[Empty name]" NAME="Furst 1997" TYPE="JOURNAL_ARTICLE">
<AU>Furst P, Pogan K, Stehle P</AU>
<TI>Glutamine dipeptides in clinical nutrition</TI>
<SO>Nutrition</SO>
<YR>1997</YR>
<VL>13</VL>
<NO>7-8</NO>
<PG>731-7</PG>
<IDENTIFIERS MODIFIED="2014-11-16 20:04:13 -0500" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2014-11-16 20:04:13 -0500" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="9263278"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Garlick-2001" MODIFIED="2014-11-16 20:04:54 -0500" MODIFIED_BY="[Empty name]" NAME="Garlick 2001" TYPE="JOURNAL_ARTICLE">
<AU>Garlick PJ</AU>
<TI>Assessment of the safety of glutamine and other amino acids</TI>
<SO>Journal of Nutrition</SO>
<YR>2001</YR>
<VL>131</VL>
<NO>9 Suppl</NO>
<PG>2556S-61S</PG>
<IDENTIFIERS MODIFIED="2014-11-16 20:04:54 -0500" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2014-11-16 20:04:54 -0500" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="11533313"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Hajivassiliou-2003" MODIFIED="2012-04-18 20:20:59 -0400" MODIFIED_BY="[Empty name]" NAME="Hajivassiliou 2003" TYPE="JOURNAL_ARTICLE">
<AU>Hajivassiliou CA</AU>
<TI>Intestinal obstruction in neonatal/pediatric surgery</TI>
<SO>Seminars in Pediatric Surgery</SO>
<YR>2003</YR>
<VL>12</VL>
<NO>4</NO>
<PG>241-53</PG>
<IDENTIFIERS MODIFIED="2012-03-29 06:07:51 -0400" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="14655163"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Kalhan-2005" MODIFIED="2014-11-16 20:06:00 -0500" MODIFIED_BY="[Empty name]" NAME="Kalhan 2005" TYPE="JOURNAL_ARTICLE">
<AU>Kalhan SC, Parimi PS, Gruca LL, Hanson RW</AU>
<TI>Glutamine supplement with parenteral nutrition decreases whole body proteolysis in low birth weight infants</TI>
<SO>Journal of Pediatrics</SO>
<YR>2005</YR>
<VL>146</VL>
<NO>5</NO>
<PG>642-7</PG>
<IDENTIFIERS MODIFIED="2014-11-16 20:06:00 -0500" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2014-11-16 20:06:00 -0500" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="15870668"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Kays-1996" MODIFIED="2012-04-18 20:23:21 -0400" MODIFIED_BY="[Empty name]" NAME="Kays 1996" TYPE="JOURNAL_ARTICLE">
<AU>Kays DW</AU>
<TI>Surgical conditions of the neonatal intestinal tract</TI>
<SO>Clinics in Perinatology</SO>
<YR>1996</YR>
<VL>23</VL>
<NO>2</NO>
<PG>353-75</PG>
<IDENTIFIERS MODIFIED="2012-03-29 06:07:51 -0400" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="8780909"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Khan-1991" MODIFIED="2014-11-16 20:06:58 -0500" MODIFIED_BY="[Empty name]" NAME="Khan 1991" TYPE="JOURNAL_ARTICLE">
<AU>Khan K, Hardy G, McElroy B, Elia M</AU>
<TI>The stability of L-glutamine in total parenteral nutrition solutions</TI>
<SO>Clinical Nutrition</SO>
<YR>1991</YR>
<VL>10</VL>
<NO>4</NO>
<PG>193-8</PG>
<IDENTIFIERS MODIFIED="2014-11-16 20:06:58 -0500" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2014-11-16 20:06:58 -0500" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="16839918"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Klimberg-1990" MODIFIED="2014-11-16 20:07:45 -0500" MODIFIED_BY="[Empty name]" NAME="Klimberg 1990" TYPE="JOURNAL_ARTICLE">
<AU>Klimberg VS, Salloum RM, Kasper M, Plumley DA, Dolson DJ, Hautamaki RD, et al</AU>
<TI>Oral glutamine accelerates healing of the small intestine and improves outcome after whole abdominal radiation</TI>
<SO>Archives of Surgery</SO>
<YR>1990</YR>
<VL>125</VL>
<NO>8</NO>
<PG>1040-5</PG>
<IDENTIFIERS MODIFIED="2014-11-16 20:07:45 -0500" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2014-11-16 20:07:45 -0500" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="2378557"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Lacey-1990" MODIFIED="2014-11-16 20:08:20 -0500" MODIFIED_BY="[Empty name]" NAME="Lacey 1990" TYPE="JOURNAL_ARTICLE">
<AU>Lacey JM, Wilmore DW</AU>
<TI>Is glutamine a conditionally essential amino acid?</TI>
<SO>Nutrition Reviews</SO>
<YR>1990</YR>
<VL>48</VL>
<NO>8</NO>
<PG>297-309</PG>
<IDENTIFIERS MODIFIED="2014-11-16 20:08:20 -0500" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2014-11-16 20:08:20 -0500" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="2080048"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Lefebvre-2008" MODIFIED="2014-11-23 21:50:14 -0500" MODIFIED_BY="[Empty name]" NAME="Lefebvre 2008" TYPE="JOURNAL_ARTICLE">
<AU>Lefebvre C, Eisinga A, McDonald S, Paul N</AU>
<TI>Enhancing access to reports of randomised trials published world-wide - the contribution of EMBASE records to the Cochrane Central Register of Controlled Trials (CENTRAL) in The Cochrane Library</TI>
<SO>Emerging Themes in Epidemiology</SO>
<YR>2008</YR>
<VL>5</VL>
<PG>13</PG>
<IDENTIFIERS MODIFIED="2014-11-16 20:10:01 -0500" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2014-11-16 20:10:01 -0500" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1186/1742-7622-5-13"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Lefebvre-2011" MODIFIED="2014-10-09 05:52:15 -0400" MODIFIED_BY="[Empty name]" NAME="Lefebvre 2011" TYPE="BOOK_SECTION">
<AU>Lefebvre C, Manheimer E, Glanville J</AU>
<TI>Chapter 6: Searching for studies</TI>
<SO>Cochrane Handbook for Systematic Reviews of Interventions</SO>
<YR>2011</YR>
<EN>5.1.0 (updated March 2011)</EN>
<ED>Higgins JPT, Green S</ED>
<PB>The Cochrane Collaboration</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-McCauley-1991" MODIFIED="2014-11-16 20:10:49 -0500" MODIFIED_BY="[Empty name]" NAME="McCauley 1991" TYPE="JOURNAL_ARTICLE">
<AU>McCauley R, Platell C, Hall J, McCulloch R</AU>
<TI>Effects of glutamine infusion on colonic anastomotic strength in the rat</TI>
<SO>Journal of Parenteral and Enteral Nutrition</SO>
<YR>1991</YR>
<VL>15</VL>
<NO>4</NO>
<PG>437-9</PG>
<IDENTIFIERS MODIFIED="2014-11-16 20:10:49 -0500" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2014-11-16 20:10:49 -0500" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="1910108"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Moe_x002d_Byrne-2012" MODIFIED="2012-04-18 20:29:23 -0400" MODIFIED_BY="[Empty name]" NAME="Moe-Byrne 2012" TYPE="COCHRANE_REVIEW">
<AU>Moe-Byrne T, Wagner JVE, McGuire W</AU>
<TI>Glutamine supplementation to prevent morbidity and mortality in preterm infants</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2012</YR>
<NO>3</NO>
<IDENTIFIERS MODIFIED="2012-04-18 20:29:23 -0400" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2012-04-18 20:29:23 -0400" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD001457.pub4"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Murray-2009" MODIFIED="2012-04-25 12:53:28 -0400" MODIFIED_BY="[Empty name]" NAME="Murray 2009" TYPE="COCHRANE_REVIEW">
<AU>Murray SM, Pindoria S</AU>
<TI>Nutrition support for bone marrow transplant patients</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2009</YR>
<NO>1</NO>
<IDENTIFIERS MODIFIED="2012-04-25 12:53:28 -0400" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2012-04-25 12:53:28 -0400" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD002920.pub3"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Newsholme-1999" MODIFIED="2014-11-16 20:12:10 -0500" MODIFIED_BY="[Empty name]" NAME="Newsholme 1999" TYPE="JOURNAL_ARTICLE">
<AU>Newsholme P, Curi R, Pithon Curi TC, Murphy CJ, Garcia C, Pires de Melo M</AU>
<TI>Glutamine metabolism by lymphocytes, macrophages, and neutrophils: its importance in health and disease</TI>
<SO>Journal of Nutritional Biochemistry</SO>
<YR>1999</YR>
<VL>10</VL>
<NO>6</NO>
<PG>316-24</PG>
<IDENTIFIERS MODIFIED="2014-11-16 20:12:10 -0500" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2014-11-16 20:12:10 -0500" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="15539305"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Newsholme-2001" MODIFIED="2014-11-16 20:12:51 -0500" MODIFIED_BY="[Empty name]" NAME="Newsholme 2001" TYPE="JOURNAL_ARTICLE">
<AU>Newsholme P</AU>
<TI>Why Is L-glutamine metabolism important to cells of the immune system in health, postinjury, surgery or infection?</TI>
<SO>Journal of Nutrition</SO>
<YR>2001</YR>
<VL>131</VL>
<NO>9 Suppl</NO>
<PG>2515S-22S</PG>
<IDENTIFIERS MODIFIED="2014-11-16 20:12:51 -0500" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2014-11-16 20:12:51 -0500" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="11533304"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Nolin-2001" MODIFIED="2014-10-09 06:25:09 -0400" MODIFIED_BY="[Empty name]" NAME="Nolin 2001" TYPE="JOURNAL_ARTICLE">
<AU>Nolin F, Beaumier L</AU>
<TI>Parenteral glutamine supplementation decreases whole body protein breakdown and improves net protein balance in surgical neonates</TI>
<SO>Pediatric Research</SO>
<YR>2001</YR>
<VL>49</VL>
<PG>349A</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Novak-2002" MODIFIED="2014-11-16 20:17:48 -0500" MODIFIED_BY="[Empty name]" NAME="Novak 2002" TYPE="JOURNAL_ARTICLE">
<AU>Novak F, Heyland DK, Avenell A, Drover JW, Su X</AU>
<TI>Glutamine supplementation in serious illness: a systematic review of the evidence</TI>
<SO>Critical Care Medicine</SO>
<YR>2002</YR>
<VL>30</VL>
<NO>9</NO>
<PG>2022-9</PG>
<IDENTIFIERS MODIFIED="2014-11-16 20:17:48 -0500" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2014-11-16 20:17:48 -0500" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="12352035"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Panigrahi-1997" MODIFIED="2014-11-16 20:18:34 -0500" MODIFIED_BY="[Empty name]" NAME="Panigrahi 1997" TYPE="JOURNAL_ARTICLE">
<AU>Panigrahi P, Gewolb IH, Bamford P, Horvath K</AU>
<TI>Role of glutamine in bacterial transcytosis and epithelial cell injury</TI>
<SO>Journal of Parenteral and Enteral Nutrition</SO>
<YR>1997</YR>
<VL>21</VL>
<NO>2</NO>
<PG>75-80</PG>
<IDENTIFIERS MODIFIED="2014-11-16 20:18:34 -0500" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2014-11-16 20:18:34 -0500" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="9084009"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Parimi-2004" MODIFIED="2014-11-16 20:19:28 -0500" MODIFIED_BY="[Empty name]" NAME="Parimi 2004" TYPE="JOURNAL_ARTICLE">
<AU>Parimi PS, Devapatla S, Gruca LL, Amini SB, Hanson RW, Kalhan SC</AU>
<TI>Effect of enteral glutamine or glycine on whole-body nitrogen kinetics in very-low-birth-weight infants</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>2004</YR>
<VL>79</VL>
<NO>3</NO>
<PG>402-9</PG>
<IDENTIFIERS MODIFIED="2014-11-16 20:19:28 -0500" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2014-11-16 20:19:28 -0500" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="14985214"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Parry_x002d_Billings-1990" MODIFIED="2014-11-16 20:20:04 -0500" MODIFIED_BY="[Empty name]" NAME="Parry-Billings 1990" TYPE="JOURNAL_ARTICLE">
<AU>Parry-Billings M, Evans J, Calder PC, Newsholme EA</AU>
<TI>Does glutamine contribute to immunosuppression after major burns?</TI>
<SO>Lancet</SO>
<YR>1990</YR>
<VL>336</VL>
<NO>8714</NO>
<PG>523-5</PG>
<IDENTIFIERS MODIFIED="2014-11-16 20:20:04 -0500" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2014-11-16 20:20:04 -0500" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="1975037"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Parry_x002d_Billings-1992" MODIFIED="2014-11-16 20:20:42 -0500" MODIFIED_BY="[Empty name]" NAME="Parry-Billings 1992" TYPE="JOURNAL_ARTICLE">
<AU>Parry-Billings M, Baigrie RJ, Lamont PM, Morris PJ, Newsholme EA</AU>
<TI>Effects of major and minor surgery on plasma glutamine and cytokine levels</TI>
<SO>Archives of Surgery</SO>
<YR>1992</YR>
<VL>127</VL>
<NO>10</NO>
<PG>1237-40</PG>
<IDENTIFIERS MODIFIED="2014-11-16 20:20:42 -0500" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2014-11-16 20:20:42 -0500" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="1358047"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Pierro-2002" MODIFIED="2014-11-16 20:21:26 -0500" MODIFIED_BY="[Empty name]" NAME="Pierro 2002" TYPE="JOURNAL_ARTICLE">
<AU>Pierro A</AU>
<TI>Metabolism and nutritional support in the surgical neonate</TI>
<SO>Journal of Pediatric Surgery</SO>
<YR>2002</YR>
<VL>37</VL>
<NO>6</NO>
<PG>811-22</PG>
<IDENTIFIERS MODIFIED="2014-11-16 20:21:26 -0500" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2014-11-16 20:21:26 -0500" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="12037742"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Rees-2007" MODIFIED="2014-11-16 20:22:14 -0500" MODIFIED_BY="[Empty name]" NAME="Rees 2007" TYPE="JOURNAL_ARTICLE">
<AU>Rees CM, Pierro A, Eaton S</AU>
<TI>Neurodevelopmental outcomes of neonates with medically and surgically treated necrotizing enterocolitis</TI>
<SO>Archives of Disease in Childhood. Fetal and Neonatal Edition</SO>
<YR>2007</YR>
<VL>92</VL>
<NO>3</NO>
<PG>F193-8</PG>
<IDENTIFIERS MODIFIED="2014-11-16 20:22:14 -0500" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2014-11-16 20:22:14 -0500" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="16984980"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Rombeau-1990" MODIFIED="2014-11-16 20:22:49 -0500" MODIFIED_BY="[Empty name]" NAME="Rombeau 1990" TYPE="JOURNAL_ARTICLE">
<AU>Rombeau JL</AU>
<TI>A review of the effects of glutamine-enriched diets on experimentally induced enterocolitis</TI>
<SO>Journal of Parenteral and Enteral Nutrition</SO>
<YR>1990</YR>
<VL>14</VL>
<NO>4 Suppl</NO>
<PG>100S-5S</PG>
<IDENTIFIERS MODIFIED="2014-11-16 20:22:49 -0500" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2014-11-16 20:22:49 -0500" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="2119454"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Stoll-2004" MODIFIED="2014-11-16 20:23:47 -0500" MODIFIED_BY="[Empty name]" NAME="Stoll 2004" TYPE="JOURNAL_ARTICLE">
<AU>Stoll BJ, Hansen NI, Adams-Chapman I, Fanaroff AA, Hintz SR, Vohr B, et al</AU>
<TI>Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection</TI>
<SO>JAMA</SO>
<YR>2004</YR>
<VL>292</VL>
<NO>19</NO>
<PG>2357-65</PG>
<IDENTIFIERS MODIFIED="2014-11-16 20:23:43 -0500" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2014-11-16 20:23:43 -0500" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="15547163"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Van-der-Hulst-1993" MODIFIED="2014-11-16 20:25:06 -0500" MODIFIED_BY="[Empty name]" NAME="Van der Hulst 1993" TYPE="JOURNAL_ARTICLE">
<AU>van der Hulst RR, van Kreel BK, von Meyenfeldt MF, Brummer RJ, Arends JW, Deutz NE, et al</AU>
<TI>Glutamine and the preservation of gut integrity</TI>
<SO>Lancet</SO>
<YR>1993</YR>
<VL>341</VL>
<NO>8857</NO>
<PG>1363-5</PG>
<IDENTIFIERS MODIFIED="2014-11-16 20:25:06 -0500" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2014-11-16 20:25:06 -0500" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="8098788"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Walsh-1986" MODIFIED="2014-11-16 20:25:42 -0500" MODIFIED_BY="[Empty name]" NAME="Walsh 1986" TYPE="JOURNAL_ARTICLE">
<AU>Walsh MC, Kliegman RM</AU>
<TI>Necrotizing enterocolitis: treatment based on staging criteria</TI>
<SO>Pediatric Clinics of North America</SO>
<YR>1986</YR>
<VL>33</VL>
<NO>1</NO>
<PG>179-201</PG>
<IDENTIFIERS MODIFIED="2014-11-16 20:25:42 -0500" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2014-11-16 20:25:42 -0500" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="3081865"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Windmueller-1980" MODIFIED="2014-11-16 20:26:27 -0500" MODIFIED_BY="[Empty name]" NAME="Windmueller 1980" TYPE="JOURNAL_ARTICLE">
<AU>Windmueller HG, Spaeth AE</AU>
<TI>Respiratory fuels and nitrogen metabolism in vivo in small intestine of fed rats. Quantitative importance of glutamine, glutamate, and aspartate</TI>
<SO>Journal of Biological Chemistry</SO>
<YR>1980</YR>
<VL>255</VL>
<NO>1</NO>
<PG>107-12</PG>
<IDENTIFIERS MODIFIED="2014-11-16 20:26:27 -0500" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2014-11-16 20:26:27 -0500" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="7350142"/>
</IDENTIFIERS>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES MODIFIED="2014-09-25 09:52:06 -0400" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Brown-2012" MODIFIED="2014-09-25 09:52:05 -0400" MODIFIED_BY="[Empty name]" NAME="Brown 2012" TYPE="COCHRANE_REVIEW">
<AU>Brown JVE, Moe-Byrne T, Grover Z, McGuire W</AU>
<TI>Glutamine supplementation for young infants with severe gastrointestinal disease</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2012</YR>
<NO>7</NO>
<IDENTIFIERS MODIFIED="2014-09-25 09:52:05 -0400" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2014-09-25 09:52:05 -0400" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD005947.pub3"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Grover-2007" MODIFIED="2012-04-18 16:23:07 -0400" MODIFIED_BY="[Empty name]" NAME="Grover 2007" TYPE="COCHRANE_REVIEW">
<AU>Grover Z, Tubman R, McGuire W</AU>
<TI>Glutamine supplementation for young infants with severe gastrointestinal disease</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2007</YR>
<NO>1</NO>
<IDENTIFIERS MODIFIED="2012-04-18 16:23:07 -0400" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2012-04-18 16:23:07 -0400" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD005947.pub2"/>
</IDENTIFIERS>
</REFERENCE>
</OTHER_VERSIONS_REFERENCES>
<PENDING_REFERENCES/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2014-11-23 21:38:43 -0500" MODIFIED_BY="[Empty name]">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2014-11-23 21:38:43 -0500" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2014-11-23 20:39:48 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Albers-2005">
<CHAR_METHODS MODIFIED="2011-12-05 05:48:11 -0500" MODIFIED_BY="Jennifer V E Wagner">
<P>Randomised controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-11-23 20:37:29 -0500" MODIFIED_BY="[Empty name]">
<P>80 children of gestational age &gt; 30 weeks and chronological age &lt; 2 years</P>
<P>Exclusion criteria: renal or hepatic dysfunction, an inborn error of metabolism, immunodeficiency, use of corticosteroids, pre-existent life expectancy &lt; 6 months, and simultaneous participation in another trial<BR/>Setting: Sophia Children's Hospital/Erasmus Medical Centre, Rotterdam, the Netherlands<BR/>1 infant was withdrawn from the study within 3 days post-randomisation when it became clear that enteral feeding would be well tolerated. This infant was not included in any intention-to-treat analyses.<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-11-23 20:38:46 -0500" MODIFIED_BY="[Empty name]">
<P>Intervention (n = 41): on the second postoperative day infants in the intervention group received a standard parenteral nutrition solution supplemented with L-glutamine sufficient to provide 0.4 g/kg/day.</P>
<P>Control (n = 39): infants received parenteral nutrition with an iso-nitrogenous amino acid solution.<BR/>The protocol specified that participating infants should continue to receive full parenteral nutrition until at least the 6th postoperative day when enteral feeding was gradually re-introduced.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-05-14 10:48:21 -0400" MODIFIED_BY="Jennifer V E Wagner">
<P>1. Intestinal permeability (sugar absorption test)<BR/>2. Nitrogen balance<BR/>3. Death prior to hospital discharge<BR/>4. Length of intensive care unit and hospital stay<BR/>5. Episodes of invasive infection<BR/>6. Use of antibiotics</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-11-23 20:39:48 -0500" MODIFIED_BY="[Empty name]">
<P>This trial did not strictly fulfil our a priori population criterion of including only infants &lt; 3 months old. However, we made a consensus decision to include the trial because the report stated that most (69 of the 80) participants were &lt; 6 months old at enrolment. We have contacted the trial investigator to determine whether outcome data are available for infants less than 3 months old.<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-05-14 12:27:26 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Duggan-2004">
<CHAR_METHODS MODIFIED="2011-12-05 05:18:13 -0500" MODIFIED_BY="Jennifer V E Wagner">
<P>Randomised controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-05-14 10:48:33 -0400" MODIFIED_BY="[Empty name]">
<P>20 infants with significant gastrointestinal illness including NEC requiring laparotomy and resection, intestinal atresia, omphalocoele, gastroschisis, intestinal volvulus, or malrotation</P>
<P>Exclusion criteria: significant hepatic, renal, or metabolic disease necessitating protein restriction &lt; 1.0 g/kg/day; significant extra-intestinal disease (cystic fibrosis, severe hypoxic ischaemic encephalopathy); or extreme short bowel syndrome (defined as &lt; 25 cm of residual bowel length)<BR/>Setting: Children's Hospital, Boston, USA</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-05-14 10:48:38 -0400" MODIFIED_BY="[Empty name]">
<P>Intervention (n = 9): glutamine-supplemented (up to 0.31 g/kg/day) expressed human milk or hydrolysed formula milk<BR/>Control (n = 11): human milk or formula without added glutamine<BR/>The study milk was introduced when infants were assessed as ready to tolerate enteral feeding and continued until day 30</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-04-17 21:29:41 -0400" MODIFIED_BY="[Empty name]">
<P>1. Time taken to establish full enteral feeding<BR/>2. Rates of nosocomial infection<BR/>3. Growth during the study period<BR/>4. In hospital mortality (personal communication from trial investigators)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-05-14 12:27:26 -0400" MODIFIED_BY="Anne Lawson"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-11-23 21:30:44 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ong-2012">
<CHAR_METHODS MODIFIED="2014-10-01 05:07:27 -0400" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-10-01 05:11:03 -0400" MODIFIED_BY="[Empty name]">
<P>174 infants with significant gastrointestinal illness, including abdominal wall defect, congenital bowel obstruction, and NEC</P>
<P>Exclusion criteria: renal failure, inborn errors of metabolism or immune deficiency</P>
<P>Setting: 14 paediatric surgical units in the UK</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-11-23 21:30:44 -0500" MODIFIED_BY="[Empty name]">
<P>Intervention (n = 87): parenteral nutrition supplemented with glutamine dipeptide (0.6 g/kg/d)</P>
<P>Control (n = 87): isonitrogenous, isocaloric parenteral nutrition solution</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-10-01 05:15:36 -0400" MODIFIED_BY="[Empty name]">
<P>1. Time on parenteral nutrition</P>
<P>2. Time to full enteral feeding</P>
<P>3. Incidence of sepsis and septicaemia</P>
<P>Adverse events and mortality also reported</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-10-16 09:30:38 -0400" MODIFIED_BY="[Empty name]">
<P>This trial was stopped when funding came to an end before the target of 250 participants was achieved. It was judged that there was a less than 5% chance of identifying the specified differences in the primary outcome measure (duration of parenteral nutrition), even if recruitment had continued as planned.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>NEC: necrotising enterocolitis</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2014-10-09 06:19:35 -0400" MODIFIED_BY="[Empty name]" SORT_BY="STUDY">
<EXCLUDED_CHAR MODIFIED="2012-05-14 10:48:55 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Barbosa-1999">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-05-14 10:48:55 -0400" MODIFIED_BY="[Empty name]">
<P>Most participants in this small trial (n = 9) were infants with non-gastrointestinal disease<BR/>
</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-12-05 09:19:54 -0500" MODIFIED_BY="Thirimon Moe Byrne" STUDY_ID="STD-Ehrenkranz-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-12-05 09:19:54 -0500" MODIFIED_BY="Thirimon Moe Byrne">
<P>Did not focus on infants with gastrointestinal disease</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-10-09 06:19:35 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Nolin-2000">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-10-09 06:19:35 -0400" MODIFIED_BY="[Empty name]">
<P>Did not focus on infants with gastrointestinal disease</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES MODIFIED="2014-10-09 06:19:49 -0400" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<AWAITING_CHAR MODIFIED="2014-10-09 06:19:49 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-NCT00647036">
<CHAR_METHODS MODIFIED="2014-10-09 06:19:49 -0400" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-10-09 06:19:49 -0400" MODIFIED_BY="[Empty name]">
<P>Surgical infants requiring total parenteral nutrition<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-10-09 06:19:49 -0400" MODIFIED_BY="[Empty name]"/>
<CHAR_OUTCOMES MODIFIED="2014-10-09 06:19:49 -0400" MODIFIED_BY="[Empty name]"/>
<CHAR_NOTES MODIFIED="2014-10-09 06:19:49 -0400" MODIFIED_BY="[Empty name]"/>
</AWAITING_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES MODIFIED="2014-10-09 06:19:49 -0400" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2014-11-23 21:38:43 -0500" MODIFIED_BY="[Empty name]">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2014-10-16 09:17:27 -0400" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Random sequence generation (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-05-14 10:48:28 -0400" MODIFIED_BY="Jennifer V E Wagner" RESULT="YES" STUDY_ID="STD-Albers-2005">
<DESCRIPTION>
<P>Computer generated, blocks of 4</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-05-14 10:48:45 -0400" MODIFIED_BY="Jennifer V E Wagner" RESULT="YES" STUDY_ID="STD-Duggan-2004">
<DESCRIPTION>
<P>Random numbers list in blocks of 4</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-10-16 09:17:27 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ong-2012">
<DESCRIPTION>
<P>Methods used to generate sequence in pharmacy not stated explicitly</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2014-11-23 21:38:23 -0500" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Allocation concealment (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-12-05 09:24:00 -0500" MODIFIED_BY="Jennifer V E Wagner" RESULT="YES" STUDY_ID="STD-Albers-2005">
<DESCRIPTION>
<P>Randomisation schedule available only to pharmacist</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-12-05 05:17:11 -0500" MODIFIED_BY="Jennifer V E Wagner" RESULT="YES" STUDY_ID="STD-Duggan-2004">
<DESCRIPTION>
<P>Sealed envelopes, opened by hospital pharmacists</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-11-23 21:38:23 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ong-2012">
<DESCRIPTION>
<P>Infants allocated to groups by central pharmacy, allocation communicated to pharmacy of recruiting centre and not shared outside of pharmacy</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" NO="3">
<NAME>Blinding (performance bias and detection bias)</NAME>
<DESCRIPTION>
<P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="GROUP" MODIFIED="2014-10-16 09:17:34 -0400" MODIFIED_BY="[Empty name]" NO="7">
<NAME>Blinding of participants and personnel (performance bias)</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-07.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2011-12-05 05:30:18 -0500" MODIFIED_BY="Jennifer V E Wagner" RESULT="YES" STUDY_ID="STD-Albers-2005">
<DESCRIPTION>
<P>Physicians and nurses blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2011-12-05 05:17:36 -0500" MODIFIED_BY="Jennifer V E Wagner" RESULT="YES" STUDY_ID="STD-Duggan-2004">
<DESCRIPTION>
<P>Investigators, parents, physicians, nurses blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-10-16 09:17:34 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ong-2012">
<DESCRIPTION>
<P>Parents, nurses, physicians, surgeons, and trial coordinator blinded</P>
<P>Allocation was revealed in one case (control group) where clinically necessary</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="GROUP" NO="8">
<NAME>Blinding of outcome assessment (detection bias)</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2014-11-23 21:38:43 -0500" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Incomplete outcome data (attrition bias)</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-03-29 04:55:24 -0400" MODIFIED_BY="Jennifer V E Wagner" RESULT="YES" STUDY_ID="STD-Albers-2005">
<DESCRIPTION>
<P>Data were analysed by intention-to-treat</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-05-14 10:48:50 -0400" MODIFIED_BY="Jennifer V E Wagner" RESULT="YES" STUDY_ID="STD-Duggan-2004">
<DESCRIPTION>
<P>&gt; 80% followed up</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-11-23 21:38:43 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ong-2012">
<DESCRIPTION>
<P>&gt; 80% followed up, any loss to follow-up explained and balanced across groups</P>
<P>4 infants in each group who had "intervention discontinued" were not included in final analyses by intention to treat</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" NO="5">
<NAME>Selective reporting (reporting bias)</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" NO="6">
<NAME>Other bias</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES/>
<ADDITIONAL_TABLES/>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2014-10-16 09:09:50 -0400" MODIFIED_BY="[Empty name]">
<COMPARISON ID="CMP-001" MODIFIED="2014-10-16 09:09:50 -0400" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Glutamine supplementation (parenteral or enteral) versus no supplementation</NAME>
<DICH_OUTCOME CHI2="2.314691168557886" CI_END="3.204219391071231" CI_START="0.19375848952151956" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7879369957741069" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" I2="13.595384681661315" I2_Q="0.0" ID="CMP-001.01" LOG_CI_END="0.5057222443253228" LOG_CI_START="-0.7127392598070615" LOG_EFFECT_SIZE="-0.10350850774086938" METHOD="MH" MODIFIED="2014-10-16 09:09:50 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.31431945235663217" P_Q="1.0" P_Z="0.7391353903792119" Q="0.0" RANDOM="NO" SCALE="111.16091365914713" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="132" TOTAL_2="131" WEIGHT="100.0" Z="0.3329985339340643">
<NAME>Death prior to hospital discharge</NAME>
<GROUP_LABEL_1>Glutamine</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours glutamine</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="93.71413772228308" CI_START="0.23001996254674012" EFFECT_SIZE="4.642857142857143" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="1.9718051135304187" LOG_CI_START="-0.6382344716011834" LOG_EFFECT_SIZE="0.6667853209646176" ORDER="271" O_E="0.0" SE="1.5331501722106189" STUDY_ID="STD-Albers-2005" TOTAL_1="41" TOTAL_2="38" VAR="2.3505494505494506" WEIGHT="11.832500960430274"/>
<DICH_DATA CI_END="8.778778178034305" CI_START="0.01822577091654301" EFFECT_SIZE="0.4" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9434340754206604" LOG_CI_START="-1.7393140927647355" LOG_EFFECT_SIZE="-0.3979400086720376" ORDER="272" O_E="0.0" SE="1.5758595538097082" STUDY_ID="STD-Duggan-2004" TOTAL_1="9" TOTAL_2="11" VAR="2.483333333333333" WEIGHT="31.1179408374952"/>
<DICH_DATA CI_END="4.102694676121821" CI_START="0.009749689693655453" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6130691978322674" LOG_CI_START="-2.011009206504305" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2014-10-16 09:09:50 -0400" MODIFIED_BY="[Empty name]" ORDER="6" O_E="0.0" SE="1.5413966441048945" STUDY_ID="STD-Ong-2012" TOTAL_1="82" TOTAL_2="82" VAR="2.375903614457831" WEIGHT="57.049558202074536"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.4688427414864807" CI_END="2.11178887022005" CI_START="0.8871868714651765" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="1.368777323367649" ESTIMABLE="YES" EVENTS_1="37" EVENTS_2="27" I2="0.0" I2_Q="0.0" ID="CMP-001.02" LOG_CI_END="0.32465049668289025" LOG_CI_START="-0.05198489347343134" LOG_EFFECT_SIZE="0.13633280160472944" METHOD="MH" MODIFIED="2014-10-09 11:49:48 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.7910286180366769" P_Q="1.0" P_Z="0.15592290253064758" Q="0.0" RANDOM="NO" SCALE="5.8433486667057934" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="132" TOTAL_2="131" WEIGHT="100.0" Z="1.4189180732368805">
<NAME>Incidence of invasive infection</NAME>
<GROUP_LABEL_1>Glutamine</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours glutamine</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="3.5375773610708854" CI_START="0.5463564216398655" EFFECT_SIZE="1.3902439024390243" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="6" LOG_CI_END="0.5487059459510988" LOG_CI_START="-0.26252394804558704" LOG_EFFECT_SIZE="0.14309099895275587" ORDER="273" O_E="0.0" SE="0.47652045538639215" STUDY_ID="STD-Albers-2005" TOTAL_1="41" TOTAL_2="38" VAR="0.22707174440165453" WEIGHT="23.127908616556198"/>
<DICH_DATA CI_END="3.86707806650227" CI_START="0.17168600452956775" EFFECT_SIZE="0.8148148148148148" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.5873829394661192" LOG_CI_START="-0.7652651061396814" LOG_EFFECT_SIZE="-0.0889410833367811" ORDER="274" O_E="0.0" SE="0.7945521577046601" STUDY_ID="STD-Duggan-2004" TOTAL_1="9" TOTAL_2="11" VAR="0.6313131313131312" WEIGHT="10.026794528275278"/>
<DICH_DATA CI_END="2.4227385202410243" CI_START="0.8611823916015724" EFFECT_SIZE="1.4444444444444444" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="18" LOG_CI_END="0.3843065444122462" LOG_CI_START="-0.0649048586772224" LOG_EFFECT_SIZE="0.15970084286751188" MODIFIED="2014-10-01 08:29:36 -0400" MODIFIED_BY="[Empty name]" ORDER="7" O_E="0.0" SE="0.26386900180706147" STUDY_ID="STD-Ong-2012" TOTAL_1="82" TOTAL_2="82" VAR="0.069626850114655" WEIGHT="66.84529685516853"/>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="14.246680281932418" CI_START="-6.646680281932417" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="3.8000000000000007" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.03" MODIFIED="2012-05-14 10:50:54 -0400" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Q="1.0" P_Z="0.4758824822347403" Q="0.0" RANDOM="NO" SCALE="15.27" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="9" TOTAL_2="11" UNITS="" WEIGHT="99.99999999999999" Z="0.7129406605975414">
<NAME>Weight gain during trial period (g/day)</NAME>
<GROUP_LABEL_1>Glutamine</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours glutamine</GRAPH_LABEL_2>
<CONT_DATA CI_END="14.246680281932418" CI_START="-6.646680281932417" EFFECT_SIZE="3.8000000000000007" ESTIMABLE="YES" MEAN_1="17.6" MEAN_2="13.8" ORDER="275" SD_1="6.4" SD_2="16.2" SE="5.330036860031357" STUDY_ID="STD-Duggan-2004" TOTAL_1="9" TOTAL_2="11" WEIGHT="99.99999999999999"/>
</CONT_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES MODIFIED="2014-11-23 21:38:44 -0500" MODIFIED_BY="[Empty name]">
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-01" MODIFIED="2014-11-23 21:38:44 -0500" MODIFIED_BY="[Empty name]" NO="1" REF_ID="CMP-001.01" SETTINGS="SHOW_RAW_DATA_COLUMNS:YES;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_MORE_DECIMALS:NO;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison 1: glutamine supplementation (parenteral or enteral) versus no supplementation, outcome 1.1: death prior to hospital discharge.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAqwAAACwCAMAAAD9l8zLAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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=
</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-02" MODIFIED="2014-11-23 21:38:44 -0500" MODIFIED_BY="[Empty name]" NO="2" REF_ID="CMP-001.02" SETTINGS="SHOW_RAW_DATA_COLUMNS:YES;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_MORE_DECIMALS:NO;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison 1: glutamine supplementation (parenteral or enteral) versus no supplementation, outcome 1.2: incidence of invasive infection.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAqwAAACwCAMAAAD9l8zLAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-03" MODIFIED="2014-11-23 21:38:44 -0500" MODIFIED_BY="[Empty name]" NO="3" REF_ID="CMP-001.03" SETTINGS="SHOW_RAW_DATA_COLUMNS:YES;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_MORE_DECIMALS:NO;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison 1: glutamine supplementation (parenteral or enteral) versus no supplementation, outcome 1.3: weight gain during trial period (g/day).</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAt4AAACACAMAAAALUZ7DAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK/>
<APPENDICES MODIFIED="2014-10-21 15:01:17 -0400" MODIFIED_BY="[Empty name]">
<APPENDIX ID="APP-01" MODIFIED="2014-10-21 15:01:17 -0400" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2011-12-16 10:14:23 -0500" MODIFIED_BY="Thirimon Moe Byrne">Electronic search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2014-10-21 15:01:17 -0400" MODIFIED_BY="[Empty name]">
<P>
<B>
<I>Database searches</I>
</B>
</P>
<P>
<B>Cochrane Central Register of Controlled Trials (CENTRAL)</B>
</P>
<P>Wiley <A HREF="http://onlinelibrary.wiley.com/">http://onlinelibrary.wiley.com/</A>
</P>
<P>Issue 8 of 12, August 2014</P>
<P>Searched on 22<SUP>nd</SUP> September 2014. 70 records were retrieved.</P>
<OL>
<LI>MeSH descriptor: [Infant, Newborn] explode all trees 13194</LI>
<LI>MeSH descriptor: [Premature Birth] this term only 397</LI>
<LI>(neonat* or neo next nat*):ti,ab,kw 10126</LI>
<LI>(newborn* or new next born* or newly next born*):ti,ab,kw 16527</LI>
<LI>(preterm or preterms or pre next term or pre next terms):ti,ab,kw 6017</LI>
<LI>(preemie* or premie or premies):ti,ab,kw 14</LI>
<LI>(prematur* near/3 (birth* or born or deliver*)):ti,ab,kw 1126</LI>
<LI>(low near/3 (birthweight* or birth next weight*)):ti,ab,kw 3243</LI>
<LI>(lbw or vlbw or elbw):ti,ab,kw 887</LI>
<LI>infan*:ti,ab,kw 36861</LI>
<LI>(baby or babies):ti,ab,kw 3163</LI>
<LI>MeSH descriptor: [Enterocolitis, Necrotizing] this term only 121</LI>
<LI>enterocolitis:ti,ab,kw 683</LI>
<LI>NEC:ti,ab,kw 173</LI>
<LI>#1 or #2 or #3 or #4 or #5 or #6 or #7 or #8 or #9 or #10 or #11 or #12 or #13 or #14 43510</LI>
<LI>MeSH descriptor: [Glutamine] this term only 491</LI>
<LI>glutam*:ti,ab,kw 3181</LI>
<LI>levoglutam*:ti,ab,kw 0</LI>
<LI>#16 or #17 or #18 3181</LI>
<LI>#15 and #19 189</LI>
<LI>#15 and #19 in Trials 186</LI>
<LI>#15 and #19 Publication Year from 2007 to 2014, in Trials 70</LI>
</OL>
<P>
<B>Key</B>
</P>
<P>MeSH descriptor = indexing term (MeSH heading)</P>
<P>* = truncation</P>
<P>:ti,ab,kw = terms in either title or abstract or keyword fields</P>
<P>near/3 = terms within three words of each other (any order)</P>
<P>next = terms are next to each other</P>
<P>
<B>EMBASE</B>
</P>
<P>OvidSP <A HREF="http://ovidsp.ovid.com/">http://ovidsp.ovid.com/</A>
</P>
<P>1980 to 2014 Week 38</P>
<P>Searched on 22<SUP>nd</SUP> September 2014. 87 records were retrieved. A search strategy developed by <LINK REF="REF-Lefebvre-2008" TYPE="REFERENCE">Lefebvre 2008</LINK> to identify randomised trials in EMBASE was used to limit retrieval to clinical trials (lines 22-36).</P>
<OL>
<LI>exp infant/ (841476)</LI>
<LI>prematurity/ (70117)</LI>
<LI>premature labor/ (29157)</LI>
<LI>exp low birth weight/ (39329)</LI>
<LI>(neonat$ or neo nat$).ti,ab. (229859)</LI>
<LI>(newborn$ or new born$ or newly born$).ti,ab. (143427)</LI>
<LI>(preterm or preterms or pre term or pre terms).ti,ab. (60787)</LI>
<LI>(preemie$ or premie or premies).ti,ab. (154)</LI>
<LI>(prematur$ adj3 (birth$ or born or deliver$)).ti,ab. (14127)</LI>
<LI>(low adj3 (birthweight$ or birth weight$)).ti,ab. (29286)</LI>
<LI>(lbw or vlbw or elbw).ti,ab. (6941)</LI>
<LI>infan$.ti,ab. (364930)</LI>
<LI>(baby or babies).ti,ab. (64354)</LI>
<LI>necrotizing enterocolitis/ (6320)</LI>
<LI>enterocolitis.ti,ab. (9685)</LI>
<LI>NEC.ti,ab. (4115)</LI>
<LI>or/1-16 (1134787)</LI>
<LI>glutamine/ (28305)</LI>
<LI>glutam$.ti,ab. (162556)</LI>
<LI>levoglutam$.ti,ab. (3)</LI>
<LI>18 or 19 or 20 (173526)</LI>
<LI>random$.ti,ab. (900117)</LI>
<LI>factorial$.ti,ab. (23315)</LI>
<LI>crossover$.ti,ab. (49098)</LI>
<LI>cross-over$.ti,ab. (21608)</LI>
<LI>placebo$.ti,ab. (202020)</LI>
<LI>(doubl$ adj blind$).ti,ab. (143459)</LI>
<LI>(singl$ adj blind$).ti,ab. (14632)</LI>
<LI>assign$.ti,ab. (242053)</LI>
<LI>allocat$.ti,ab. (85229)</LI>
<LI>volunteer$.ti,ab. (177796)</LI>
<LI>Crossover Procedure/ (40222)</LI>
<LI>double blind procedure/ (115438)</LI>
<LI>Randomized Controlled Trial/ (350056)</LI>
<LI>single blind procedure/ (18827)</LI>
<LI>or/22-35 (1432268)</LI>
<LI>17 and 21 and 36 (364)</LI>
<LI>animal/ (1570185)</LI>
<LI>exp animal experiment/ (1697956)</LI>
<LI>Nonhuman/ (4374620)</LI>
<LI>(rat or rats or mouse or mice or hamster or hamsters or animal or animals or dog or dogs or cat or cats or bovine or sheep).ti,ab,sh. (4568271)</LI>
<LI>38 or 39 or 40 or 41 (6746352)</LI>
<LI>exp human/ (15016996)</LI>
<LI>human experiment/ (329080)</LI>
<LI>43 or 44 (15018382)</LI>
<LI>42 not (42 and 45) (5182957)</LI>
<LI>37 not 46 (225)</LI>
<LI>limit 47 to em=201100-201438 (87)</LI>
</OL>
<P>
<B>Key:</B>
</P>
<P>/ = indexing term (EMTREE heading)</P>
<P>$ = truncation</P>
<P>.ti,ab. = terms in either title or abstract fields</P>
<P>adj3 = terms within three words of each other (any order)</P>
<P>.sh.= subject heading field</P>
<P>.em. = entry date &#8211; date added to database</P>
<P>
<B>Maternity and Infant Care </B>
</P>
<P>OvidSP <A HREF="http://ovidsp.ovid.com/">http://ovidsp.ovid.com/</A>
</P>
<P>1971 to August 2014</P>
<P>Searched on 22<SUP>nd</SUP> September 2014. 59 records were retrieved.</P>
<OL>
<LI>Infant.de. (7384)</LI>
<LI>Infant - newborn.de. (23849)</LI>
<LI>Infant - premature.de. (7331)</LI>
<LI>infant - very premature.de. (753)</LI>
<LI>Infant - low birth weight.de. (2367)</LI>
<LI>Infant - very low birth weight.de. (2147)</LI>
<LI>Premature birth.de. (1625)</LI>
<LI>Infant - small for gestational age.de. (887)</LI>
<LI>(neonat$ or neo nat$).ti,ab. (32059)</LI>
<LI>(newborn$ or new born$ or newly born$).ti,ab. (14916)</LI>
<LI>(preterm or preterms or pre term or pre terms).ti,ab. (18476)</LI>
<LI>(preemie$ or premie or premies).ti,ab. (41)</LI>
<LI>(prematur$ adj3 (birth$ or born or deliver$)).ti,ab. (3141)</LI>
<LI>(low adj3 (birthweight$ or birth weight$)).ti,ab. (8455)</LI>
<LI>(lbw or vlbw or elbw).ti,ab. (2237)</LI>
<LI>infan$.ti,ab. (48220)</LI>
<LI>(baby or babies).ti,ab. (23514)</LI>
<LI>Enterocolitis.de. (8)</LI>
<LI>enterocolitis.ti,ab. (1349)</LI>
<LI>NEC.ti,ab. (493)</LI>
<LI>or/1-20 (94518)</LI>
<LI>Glutamine.de. (16)</LI>
<LI>glutam$.ti,ab. (161)</LI>
<LI>levoglutam$.ti,ab. (0)</LI>
<LI>22 or 23 or 24 (162)</LI>
<LI>21 and 25 (108)</LI>
<LI>limit 26 to yr="2007 -Current" (59)</LI>
</OL>
<P>
<B>Key</B>
</P>
<P>.de. = indexing term</P>
<P>$ = truncation</P>
<P>.ti,ab. = terms in either title or abstract fields</P>
<P>adj3 = terms within three words of each other (any order)</P>
<P>yr = year published</P>
<P>
<B>MEDLINE</B>
</P>
<P>OvidSP <A HREF="http://ovidsp.ovid.com/">http://ovidsp.ovid.com/</A>
</P>
<P>1946 to September week 2 2014</P>
<P>Searched on 22<SUP>nd</SUP> September 2014. 61 records were retrieved. The Cochrane highly sensitive search strategy for identifying randomized trials in MEDLINE (sensitivity-maximizing version) was used to limit retrieval to clinical trials (lines 21-31) (<LINK REF="REF-Lefebvre-2011" TYPE="REFERENCE">Lefebvre 2011</LINK>).</P>
<OL>
<LI>exp Infant, Newborn/ (504876)</LI>
<LI>Premature Birth/ (6949)</LI>
<LI>(neonat$ or neo nat$).ti,ab. (189942)</LI>
<LI>(newborn$ or new born$ or newly born$).ti,ab. (128353)</LI>
<LI>(preterm or preterms or pre term or pre terms).ti,ab. (45250)</LI>
<LI>(preemie$ or premie or premies).ti,ab. (106)</LI>
<LI>(prematur$ adj3 (birth$ or born or deliver$)).ti,ab. (11353)</LI>
<LI>(low adj3 (birthweight$ or birth weight$)).ti,ab. (24580)</LI>
<LI>(lbw or vlbw or elbw).ti,ab. (5285)</LI>
<LI>infan$.ti,ab. (323868)</LI>
<LI>(baby or babies).ti,ab. (50568)</LI>
<LI>Enterocolitis, Necrotizing/ (2030)</LI>
<LI>enterocolitis.ti,ab. (7862)</LI>
<LI>NEC.ti,ab. (2655)</LI>
<LI>or/1-14 (818716)</LI>
<LI>Glutamine/ (15076)</LI>
<LI>glutam$.ti,ab. (145071)</LI>
<LI>levoglutam$.ti,ab. (4)</LI>
<LI>16 or 17 or 18 (149488)</LI>
<LI>15 and 19 (5020)</LI>
<LI>randomized controlled trial.pt. (388375)</LI>
<LI>controlled clinical trial.pt. (89809)</LI>
<LI>randomized.ab. (284414)</LI>
<LI>placebo.ab. (150745)</LI>
<LI>drug therapy.fs. (1744932)</LI>
<LI>randomly.ab. (201022)</LI>
<LI>trial.ab. (295504)</LI>
<LI>groups.ab. (1282228)</LI>
<LI>or/21-28 (3283677)</LI>
<LI>exp animals/ not humans.sh. (4011372)</LI>
<LI>29 not 30 (2797292)</LI>
<LI>15 and 19 and 31 (437)</LI>
<LI>limit 32 to ed=20111101-20140911 (61)</LI>
</OL>
<P>
<B>Key</B>
</P>
<P>/ = indexing term (MeSH heading)</P>
<P>exp = exploded MeSH heading</P>
<P>$ = truncation</P>
<P>.ti,ab. = terms in either title or abstract fields</P>
<P>adj3 = terms within three words of each other (any order)</P>
<P>.pt. = publication type</P>
<P>.fs. = floating subheading</P>
<P>.sh.= subject heading</P>
<P>.ed. = entry date - date added to the database</P>
<P>
<B>MEDLINE In-Process &amp; Other Non-Indexed Citations</B>
</P>
<P>OvidSP <A HREF="http://ovidsp.ovid.com/">http://ovidsp.ovid.com/</A>
</P>
<P>September 19, 2014</P>
<P>Searched on 22<SUP>nd</SUP> September 2014. 60 records were retrieved.</P>
<OL>
<LI>exp Infant, Newborn/ (0)</LI>
<LI>Premature Birth/ (0)</LI>
<LI>(neonat$ or neo nat$).ti,ab. (10428)</LI>
<LI>(newborn$ or new born$ or newly born$).ti,ab. (5627)</LI>
<LI>(preterm or preterms or pre term or pre terms).ti,ab. (3486)</LI>
<LI>(preemie$ or premie or premies).ti,ab. (11)</LI>
<LI>(prematur$ adj3 (birth$ or born or deliver$)).ti,ab. (623)</LI>
<LI>(low adj3 (birthweight$ or birth weight$)).ti,ab. (1523)</LI>
<LI>(lbw or vlbw or elbw).ti,ab. (432)</LI>
<LI>infan$.ti,ab. (16416)</LI>
<LI>(baby or babies).ti,ab. (3393)</LI>
<LI>Enterocolitis, Necrotizing/ (0)</LI>
<LI>enterocolitis.ti,ab. (468)</LI>
<LI>NEC.ti,ab. (298)</LI>
<LI>or/1-14 (30053)</LI>
<LI>Glutamine/ (0)</LI>
<LI>glutam$.ti,ab. (8117)</LI>
<LI>levoglutam$.ti,ab. (0)</LI>
<LI>16 or 17 or 18 (8117)</LI>
<LI>15 and 19 (176)</LI>
<LI>limit 20 to ed=20111101-20140918 (60)</LI>
</OL>
<P>
<B>Key</B>
</P>
<P>/ = indexing term (MeSH heading)</P>
<P>exp = exploded MeSH heading</P>
<P>$ = truncation</P>
<P>.ti,ab. = terms in either title or abstract fields</P>
<P>adj3 = terms within three words of each other (any order)</P>
<P>ed = entry date - date added to the database</P>
<P>
<B>PubMed</B>
</P>
<P>
<A HREF="http://www.ncbi.nlm.nih.gov/pubmed/">http://www.ncbi.nlm.nih.gov/pubmed/</A>
</P>
<P>Searched on 23<SUP>rd</SUP> September 2014. 82 records were retrieved. The Cochrane highly sensitive search strategy for identifying randomized trials in PubMed (sensitivity-maximizing version) was used to limit retrieval to clinical trials (<LINK REF="REF-Lefebvre-2011" TYPE="REFERENCE">Lefebvre 2011</LINK>).</P>
<P>Search (((((((((((((((((((((("Infant, Newborn"[Mesh])) OR ("Premature Birth"[Mesh])) OR (((neonat*[Title/Abstract]) OR neo nat*[Title/Abstract]) OR neo-nat*[Title/Abstract])) OR (((((newborn*[Title/Abstract]) OR new born*[Title/Abstract]) OR new-born*[Title/Abstract]) OR newly born*[Title/Abstract]) OR newly-born*[Title/Abstract])) OR ((((((preterm[Title/Abstract]) OR preterms[Title/Abstract]) OR pre term[Title/Abstract]) OR pre-term[Title/Abstract]) OR pre terms[Title/Abstract]) OR pre-terms[Title/Abstract])) OR (((preemie*[Title/Abstract]) OR premie[Title/Abstract]) OR premies[Title/Abstract])) OR ((prematur*[Title/Abstract]) AND birth*[Title/Abstract])) OR ((prematur*[Title/Abstract]) AND born[Title/Abstract])) OR ((prematur*[Title/Abstract]) AND deliver*[Title/Abstract])) OR ((low[Title/Abstract]) AND birthweight*[Title/Abstract])) OR ((low[Title/Abstract]) AND birth weight*[Title/Abstract])) OR ((low[Title/Abstract]) AND birth-weight*[Title/Abstract])) OR (((lbw[Title/Abstract]) OR vlbw[Title/Abstract]) OR elbw[Title/Abstract])) OR (infan*[Title/Abstract])) OR ((baby[Title/Abstract]) OR babies[Title/Abstract])) OR ("Enterocolitis, Necrotizing"[Mesh:noexp]) OR (enterocolitis[Title/Abstract]) OR (NEC[Title/Abstract]))) AND (((levoglutam*[Title/Abstract]) OR glutam*[Title/Abstract]) OR "Glutamine"[Mesh:noexp]))) AND (((((((((((randomized controlled trial[Publication Type])) OR (controlled clinical trial[Publication Type])) OR (randomized[Title/Abstract])) OR (placebo[Title/Abstract])) OR (drug therapy[MeSH Subheading])) OR (randomly[Title/Abstract])) OR (trial[Title/Abstract])) OR (groups[Title/Abstract]))) NOT (animals[mh] NOT humans[mh])))) AND ("2011/11/01"[Date - Entrez] : "3000"[Date - Entrez])</P>
<P>
<B>Key</B>
</P>
<P>[Mesh] = exploded Medical Subject heading (MeSH)</P>
<P>[mh] = exploded MeSH</P>
<P>[Mesh:noexp] = MeSH not exploded</P>
<P>* = truncation</P>
<P>[Title/Abstract] = terms in either title or abstract fields</P>
<P>[Date - Entrez] = entry date - date added to the database</P>
<P>
<B>
<I>Trial register searches</I>
</B>
</P>
<P>
<B>Clinical Trials.gov</B>
</P>
<P>
<A HREF="http://clinicaltrials.gov/">http://clinicaltrials.gov/</A>
</P>
<P>Searched on 23<SUP>rd</SUP> September 2014. 17 records were retrieved in total using the following search strategies:</P>
<P>4 studies found for: Glutamine AND (infant OR infants OR newborn OR newborns OR premature OR prematurity OR neonate OR neonates OR neonatal OR preterm OR preterms OR preemie OR preemies OR premie OR premies OR birthweight OR baby OR babies) | received on or after 11/01/2011 | updated on or after 11/01/2011</P>
<P>1 study found for: Glutamine AND (NEC OR enterocolitis) | received on or after 11/01/2011 | updated on or after 11/01/2011</P>
<P>12 studies found for: "Glutamine" | Child | received on or after 11/01/2011 | updated on or after 11/01/2011</P>
<P>
<B>metaRegister of Controlled Trials (mRCT)</B>
</P>
<P>
<A HREF="http://www.controlled-trials.com/mrct/searchform">http://www.controlled-trials.com/mrct/searchform</A>
</P>
<P>Searched on 23<SUP>rd</SUP> September 2014. 18 trials were retrieved.</P>
<P>(Glutamine AND (infant OR infants OR newborn OR newborns OR premature OR prematurity OR neonate OR neonates or neonatal OR preterm OR preterms OR preemie OR preemies OR premie OR premies OR birthweight OR baby OR babies OR enterocolitis or NEC))</P>
<P>
<B>WHO International Clinical Trials Registry Platform</B>
</P>
<P>
<A HREF="http://apps.who.int/trialsearch/AdvSearch.aspx">http://apps.who.int/trialsearch/AdvSearch.aspx</A>
</P>
<P>Searched on 23<SUP>rd</SUP> September 2014. 21 trials were retrieved in total using the following search strategies:</P>
<OL>
<LI>glutam* in title, clinical trials in children &#8211; 11 trials.</LI>
<LI>glutam* in intervention field, clinical trials in children &#8211; 10 trials.</LI>
</OL>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS/>
</COCHRANE_REVIEW>